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2  INTRODUCTION 
 
I INTRODUCTION 
The vascular system continuously undergoes remodeling processes not only during the early 
development but also in the adult circulation, e.g. as consequence of exercise training or 
during the reproductive cycle. Vascular remodeling is as well a feature of vascular 
pathologies such as atherosclerosis, restenosis and collateral vessel growth 41.  
Changes in blood flow conditions and especially alterations in shear stress are one principal 
stimulus for vessel remodeling and adaptation. Previously Gloe and colleagues were able to 
show that shear stress induces the release of fibroblast growth factor-2 (FGF-2) from 
endothelial cells 75. This release process was not only dependent on the integrin αvβ3, but also 
on a serine protease with elastase activity 107. 
1 THE VASCULATURE 
The blood vessels as part of the entire cardiovascular system supply all organs with blood 
containing oxygen and nutrients essential for organ function and cellular integrity. The wall of 
a larger vessel is composed of three layers. The inner layer, the intima, is formed by a 
monolayer of endothelial cells and the basement membrane, whereas the media is composed 
of multiple layers containing variable amounts of elastic fibres and circular smooth muscle 
cells. The latter regulate the vessel width especially in small arteries and arterioles and are 
responsible for control of blood flow and flow resistance. The outer layer, the adventitia, 
mainly consists of connective tissue, containing a mixture of collagenous and elastic fibrils 
and fibroblasts (see Figure I.1) 155. 
In the embryo, the first primitive vascular network is formed by bipotent precursor cells, the 
hemangioblasts. This de novo formation of a primary vessel plexus is termed 
vasculogenesis 101. Hemodynamic forces and growth factors, especially vascular endothelial 
growth factor (VEGF), are critical in coordinating these processes and play a role in the 
ultimate shape of the vessel 185. 
 
Figure I.1: The structure of the vessel wall 
The division of the wall into three layers is the common structural pattern in all blood vessels with the 
exception of capillaries. 
INTRODUCTION  3 
1.1 THE ENDOTHELIUM 
The endothelium, a monolayer of cells, lines the inside of all blood vessels and therefore 
provides a barrier between the blood and the tissues. Endothelial cells can influence the 
underlying smooth muscle cells or circulating blood elements like platelets and white blood 
cells in a complex autocrine-paracrine set of interactions. Thereby they are involved in the 
regulation of vascular tone, permeability, angiogenesis, inflammation and coagulation. 
Endothelial cell injury, activation or dysfunction may lead to pathological states like 
atherosclerosis, thrombosis, hemostatic dysfunction or an altered inflammatory or immune 
response 185. 
Due to their direct contact to the streaming blood, endothelial cells are constantly exposed to 
biochemical and biomechanical stimuli, especially to shear stress (see Figure I.2) 163. 
Shear stress Pressure
ENDOTHELIUM
Autocrine and paracrine
acting endothelial factors
Endocrine factors
Humoral factors
1
2
3
1
 
Figure I.2: Stimuli that affect the endothelium 
Endothelial cells are influenced by (1) biomechanical stimuli like shear stress or hydrostatic pressure, 
(2) blood-borne humoral or endocrine stimuli or (3) endothelium and smooth muscle cell-derived 
stimuli acting in a paracrine or autocrine manner. Adapted from Paszkowiak and Dardik, 2003 147. 
The endothelium uniquely contains Weibel-Palade bodies, elongated storage organelles, that 
contain various substances, amongst others von Willebrand factor (vWF) and P-selectin 197. 
Those proteins are targeted into the Weibel-Palade bodies for storage. In response to 
activating stimuli such as thrombin or shear stress, these vesicles are rapidly mobilized, fuse 
with the plasma membrane and thereby allow a prompt delivery of a number of bioactive 
substances 46,67. 
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2 HEMODYNAMIC FORCES 
Arteries and veins are constantly exposed to distinct hemodynamic forces, which are 
generated by the blood flow. There are three principal types of hemodynamic forces acting on 
vascular cells: (1) the fluid shear stress, which acts in a longitudinal direction on the blood-
endothelium interface and is directly related to the flow velocity profile, (2) the pulsatile 
cyclic stretch and (3) the compressive hydrostatic pressure 68. Whereas cyclic stretch and 
pressure are transferred to the whole vessel wall due to their vertical orientation, the 
tangentially aligned shear stress is mainly sensed by the endothelium. 
2.1 SHEAR STRESS 
Shear stress is defined as the force per unit area applied to move parallel fluid layers or solid 
materials. 
Fτ = 
A
  
τ: shear stress [N · m-²] 
F: the force applied [N] 
A: the cross sectional area [m²] 
F
A
 
 
 
In vessels, the flowing blood exerts a force on the endothelial cell surface acting in flow 
direction. The occurring shear stress can be calculated using Hagen-Poiseuilles law, which is 
valid for ideal Newtonian fluids and laminar flows in stiff tubes 105. Shear stress increases 
with elevated flow velocity, greater fluid viscosity and smaller vessel diameter. 
Hagen-Poiseuille equation 
 
3
4μQτ = 
r   
τ: shear stress [N · m-²] [1 N = 105 dyn] 
μ: blood viscosity [N · s · m-²]  
Q: blood flow rate [m3 · s-1] 
r: vessel radius [m] 
 
 
 
Blood is a non-Newtonian liquid, which means that its viscosity is not only dependent on the 
temperature but also on alterations in the strain 105. Through the break-up of erythrocyte-
aggregates and deformation of these cells, blood viscosity decreases with increasing flow 
velocities (shear thinning). In blood vessels the Poiseuille equation is only applicable with 
restrictions. The equation can be applied in vivo with the following assumptions: the blood is 
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considered as a Newtonian fluid, the vessel’s cross-section is cylindrical, the vessel is straight 
with inelastic walls and the blood flow is steady and laminar 144. 
Shear stress varies depending on heart minute volume, heart period and regional differences 
in vessel geometry and thereby varies in its magnitude, frequency and direction. Large arteries 
are defined by a high-pressure, pulsatile flow with shear stresses that cycle within systole and 
diastole, reaching relatively high levels of 10 to 70 dyn/cm². The highest values appear at 
bifurcations of large central arteries. Veins experience much lower shear stresses of 
1-6 dyn/cm² with a lesser degree of force variation 144. Flow disturbances occur in arterial 
segments with geometric irregularities, like curvatures, branches or bifurcations or upstream 
and downstream of stenoses 34. 
Under normal physiological conditions, shear forces serve as an important signal to preserve 
the anti-thrombotic, anti-inflammatory, anti-oxidative stress and anti-apoptotic phenotype of 
the vascular endothelium. By contrast, lower flow velocities or disturbed, turbulent flows 
promote a proatherogenic and/or prothrombotic state and hence vascular pathologies like 
atherosclerosis and thrombosis. High shear levels are thought to play an important role during 
the formation of collateral arteries, termed arteriogenesis  26,162. 
LAMINAR FLOW DISTURBED FLOW
Chronic Acute changes Acute and chronic
1. Suppression of endothe-
lial activation genes
2. Endothelial quiescence, 
anti-apoptotic, anti-
inflammatory/atherogenic
3. Cytoskeleton/morphology
adaption to flow
1. Induction of endothelial 
activation genes
2. Endothelial activation, 
release of vasoactive
factors, survival, 
migration, ECM synthesis
1. Induction of 
inflammatory/atherogenic
genes
2. Activation, migration, 
proliferation, apoptosis, 
leukocyte binding
AtherosclerosisVascular remodelingArteriogenesisAtheroprotection  
Figure I.3: Effects of laminar and disturbed flow on endothelial cells  
The image is adapted from Resnick et al., 2003 163. 
Short term changes in blood flow through arteries result in vasodilation via the release of 
vasoactive substances, like prostacyclin, nitric oxide (NO) and endothelium-derived 
hyperpolarizing factor (EDHF), and molecules reducing platelet aggregation 27,172,192. Shear 
stress is the most potent physiological stimulus for NO production in endothelial cells 192. 
A chronic high blood flow may induce vessel remodeling, that is the formation of new 
vessels 53,95 or a structural reorganization of blood vessels as observed in arteriogenesis. It has 
been shown that an elevated flow as a consequence of exercise causes the formation of new 
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capillaries (angiogenesis) and growth of arteries in the skeletal muscle. Furthermore, 
treatment with prazosin, an α1-antagonist that induces a threefold higher capillary flow, 
increased capillary growth in muscles 48,130,156. By contrast, vessels that are not exposed to 
flow degenerate. 
It has been shown that different growth factors, including FGF-2 and PDGF (platelet-derived 
growth factor), are released by cultured smooth muscle cells after shear stress exposure in 
vitro 164,182. Furthermore, Gloe et al. demonstrated that in endothelial cells the release of 
FGF-2 strongly increases after shear stress exposure 75. 
The endothelium, which is constantly exposed to shear stress, is able to sense this physical 
stimulus. This ability of the vascular endothelium to sense and respond to the blood flow was 
observed more than 150 years ago by Virchow 163. Cells exposed to shear stress elongate and 
align in flow direction 163. Shear stress signals are thought to be mediated by ion channels, 
mechanosensitive proteins like integrins, mechanosignaling via G-proteins, receptor tyrosine 
kinases (RTKs) or adhesion molecules like platelet endothelial cell adhesion molecule-1 
(PECAM-1) (see Figure I.4). Intracellular components that have been linked to the 
mechanotransduction process are the mitogen-activated protein kinases (MAPK) 199. The 
exact mechanisms of cell mechanotransduction, especially how cells sense hemodynamic 
forces, are not yet fully understood. 
Integrins
Focal adhesion kinase
Adaptor proteins
PECAM-1
Adherens junction
(VE-Cadherin)
Extracellular matrix
Cytoskeleton
Cell-matrix
junction
Cell-cell
junction
Apical membraneApical membrane
RTKs and adaptor proteins
Ion channels
Caveolae
G-proteinsShear stress
Cell-matrix
junction
 
Figure I.4: Shear stress sensors on endothelial cells 
Mechanosensors on the apical membrane, cell-cell junctions and cell-matrix junctions are connected 
by the cell cytoskeleton. All three types of mechanosensors can be activated via shear stress. 
Adapted from Resnick et al., 2003 163. 
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3 ANGIOADAPTATION 
Vessels dynamically adjust to changes in hemodynamic and metabolic conditions. 
Zakrzewicz et al. proposed the term angioadaptation to describe this set of processes 206. It 
involves the reorganization of blood vessels via changes in vessel number or structural 
changes, which incorporate alterations in vessel diameter or wall mass. In detail, vessel 
sprouting or subdivision resulting in an increased vessel number is called angiogenesis. By 
contrast, the term pruning describes the loss of vascular segments. Structural changes in 
vessel diameter or mass are termed vascular remodeling (see Figure I.5). The lumen diameter 
can be regulated by the flow velocity: A higher blood flow leads to vasodilation whereas a 
decrease in flow velocity induces a constriction of the vessel. Since remodeling may result in 
an increase, decrease, or not change the amount of wall material, Mulvany subclassified these 
three settings as hypertrophic, hypotrophic and eutrophic remodeling 133. Clinical conditions 
that involve vascular remodeling are summarized in Table I.1. 
ANGIOADAPTATION
Angiogenesis Remodeling
Increased
number
(sprouting)
Increased
number
(intus-
susception)
Decreased
number
(pruning)
Decreased
wall mass
Decreased
diameter
Increased
wall mass
Increased
diameter
 
Figure I.5: Processes of angioadaptation 
Image modified from Zakrzewicz et al., 2002 206. 
The remodeling procedure induced by chronic shear stress or other stimuli, can be divided 
into three steps: signal detection, release of substances and, finally, the remodeling process 
per se. At first, signals are detected by endothelial cells via mechanosensory molecules (see 
Figure I.4). As a response, these cells synthesize and release substances like matrix 
modulators (enzymes), growth regulators, cytokines or vasoactive substances. These 
molecules induce changes regarding cell growth, death, migration or the formation or 
degradation of extracellular matrix and thus influence the structural composition of the vessel.  
A description of the mechanisms of angioadaptation requires the identification of the 
processes by which shear stress or other stimuli are sensed and the characterization of 
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subsequent signaling pathways leading to structural changes, including angiogenesis and 
remodeling. The next two chapters will describe the two angioadaptive processes, 
angiogenesis and arteriogenesis, in detail. 
Table I.1: Clinical conditions involving vascular remodeling 72 
Atherosclerosis 
Plaque formation 
Systemical arterial hypertension 
Pulmonary hypertension 
Stenosis of vein bypass graft 
Restenosis after angioplasty 
Collateral formation 
Glomerular sclerosis 
Arteriovenous fistula 
Aneurysm 
Patent ductus arteriosus 
Venous hypertension 
Neovascularization 
Transplantation-induced arteriopathy 
Neointimal hyperplasia 
 
 
3.1 ANGIOGENESIS 
Angiogenesis is the growth of new blood vessels by sprouting from preexisting ones or by 
intravascular subdivision (intussuception) in adult and embryonic tissue 59. Physiological and 
pathophysiological conditions that involve angiogenesis are summarized in Table I.2. 
Table I.2: Conditions involving physiological or pathophysiological angiogenesis 31,78 
Physiological angiogenesis Pathophysiological angiogenesis 
Embryonic development Tumor growth and metastasis 
Wound healing Psoriasis 
Menstrual cycle, ovulation, corpus luteum 
formation, embryo implantation 
Chronic inflammation (rheumatoid arthritis,  
Crohns disease) 
Exercise Age-related macular degeneration 
 Diabetic retinopathy 
 Cardiovascular diseases (atherosclerosis) 
 Endometriosis 
 Adiposity 
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The angiogenic cascade of the sprouting mode is composed of a complex set of sequential 
steps (see Table I.3). In brief: Hypoxic, injured or diseased tissue synthesizes and releases 
angiogenic growth factors. Binding of these growth factors to their appropriate endothelial 
receptors leads to endothelial cell activation 58. Removal of pericytes and vessel 
destabilization shifts the cells from a stable situation with less growth to a proliferating 
phenotype. Due to an increased cell permeability induced by VEGF, proteases and matrix 
components escape from the blood into the surrounding tissue. Proteases digest the basement 
membrane and the extracellular matrix and thereby release matrix-bound growth factors 
(VEGF, FGF-2). Endothelial cells migrate and proliferate through the reorganized matrix 16. 
Adhesion molecules, namely the integrins αvβ3 and αvβ5, help to move the sprouting vessel. 
Matrix metalloproteinases are produced to rearrange the extracellular matrix. The interaction 
of angiopoetin-1 (Ang1) with its receptor Tie2 modulates the tube-like structure and decreases 
vascular permeability, thereby stabilizing the newly formed vessel. Pericytes, recruited by 
PDGF and TGF-β (transforming growth factor-β), are incorporated to further stabilize the 
new blood vessel 58,198. 
Table I.3: Sequential process of normal sprouting angiogenesis 145 
Step Process Angiogenic factors 
1 Vessel destabilization Ang2/Tie2 
2a Vessel hyperpermeability VEGF, VE-cadherin 
2b Matrix remodeling TGF-β 
3 Endothelial cell proliferation VEGF, FGFs, EGF 
4 Endothelial cell migration Integrin αvβ3 and αvβ5, VEGF, FGFs 
5 Cell-cell contact VE-cadherin, ephrin-B2/Eph-B4 
6 Tube formation FGFs, PDGF, TNF-α, Eph-A2 
7 Mesenchymal proliferation/migration PDGF, Ang1/Tie2 
8 Pericyte differentiation TGF-β 
9 Vessel stabilization Ang1/Tie2, PDGF, VE-cadherin, TGF-β 
 
 
3.2 REMODELING – ARTERIOGENESIS 
The occlusion of a conduit vessel induces a rapid proliferation of preexisting collateral vessels 
involving an increase of their length and mass. The term arteriogenesis, which describes this 
phenomenon, was created more than 10 years ago by Schaper et al. 170. Collateral artery 
growth after arterial occlusion is the most important tissue-saving, organ-saving and often 
life-saving vascular adaptive process 170. 
The main elicitor for arteriogenesis is thought to be a rapidly increasing blood flow in these 
collaterals. This raised shear stress activates endothelial cells, leading to an upregulation of 
endothelial chemokines, mainly monocyte chemoattractant protein-1 (MCP-1), granulocyte-
macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-α (TNF-α), 
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adhesion molecules, like intercellular adhesion molecule-1 (ICAM-1) and endothelial nitric 
oxide synthase (eNOS) 198. MCP-1 attracts circulating monocytes, which migrate into the 
vascular wall. After their transformation to macrophages, these cells produce proteases, 
fibronectin and proteoglycans, which remodel the extracellular matrix. The inflammatory 
cells release vascular growth factors, especially FGF-2, which induce an immense growth 
process with active proliferation of endothelial and smooth muscle cells 88. Proteases alter the 
external elastic lamina and elastin, located in the adventitia and surrounding tissue, to give 
way to the growing vessel 198. 
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Figure I.6: Angiogenesis versus arteriogenesis 
Image adapted from Buschmann and Schaper, 1999 and Schaper and Scholz, 2003 25,170. 
3.3 PROTEASES 
Proteases are enzymes capable of hydrolyzing peptide bonds and thereby breaking down 
proteins. As mentioned above, extracellular proteolysis plays a crucial role in vascular 
remodeling processes and angiogenesis by degrading extracellular matrices 196. Moreover, 
proteases are involved in the regulation of growth factor bioavailability, modulation of 
cytokine activity and receptor shedding 69. Several pathological conditions including tumor 
growth, inflammatory diseases and cardiovascular conditions such as atherosclerosis and 
restenosis are linked to changes in protease activity 69. By their mechanism of hydrolytic 
cleavage, proteases can be classified as serine proteases, cysteine proteases, 
metalloproteinases, threonine proteases and aspartate proteases. Furthermore, depending on 
their site of action they are classified as exo- or endopeptidases. Endopeptidases in contrast to 
exopeptidases cleave at the inner regions of peptide chains. Most proteases that act in the 
extracellular space are serine and metalloproteinase endopeptidases, acting at a neutral pH, 
and cysteine endopeptidases, which function optimally in acidic conditions. Protease action is 
regulated by specific activation mechanisms and specific inhibitors, including tissue inhibitors 
of metalloproteinases (TIMPs) or serine protease inhibitors 196. 
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3.3.1 Elastase 
Our group was able to show that a serine protease with elastase activity is important for shear 
stress induced signaling processes 107. Historically, the term elastase describes proteases 
having the ability to cleave elastin 17. Different proteases from the metalloproteinase, cysteine 
and serine protease familiy have been shown to degrade elastin. However, the name elastase 
is now applied to neutrophil and pancreatic elastase, which are serine proteases belonging to 
the chymotrypsin family 87. Both enzymes cleave elastin, but elastin is neither their only, nor 
necessarily their most important substrate 17. 
Neutrophil elastase is primarily located in the azurophilic granules of polymorphonuclear 
leukocytes, but has also been detected in the nuclear membrane, the Golgi complex, the 
endoplasmic reticulum (ER) and the mitochondria of these cells. Furthermore, neutrophil 
elastase can be found in granules of monocytes 103. The enzyme is essential for phagocytosis 
and defense against infection by invading microorganisms and participates in tissue 
remodeling and is thereby implicated in numerous diseases, including emphysema, chronic 
obstructive pulmonary disease, cystic fibrosis, acute respiratory distress syndrome, ischemia 
reperfusion injury and rheumatoid arthritis 193. Pancreatic elastase is stored as an inactive 
zymogen in the pancreas. It is secreted into the intestines, where it is activated by trypsin and 
participates in digestion 17. 
For humans, six genes have been described and are listed in NCBI 136. These are one 
neutrophil (ELANE, synonym ELA2) and five pancreatic elastases (ELA1, 2A, 2B, 3A, 3B). 
The comparison of their coding sequences is shown in Figure I.7. Below, in Figure I.8, the six 
human genes are compared with the two porcine elastase genes that are listed in NCBI. The 
porcine ELS1 gene shows most homologies to the human ELA1 gene. Surprisingly, the 
porcine ELANE gene is not highly related to the human neutrophil elastase gene (ELANE), 
but to the human pancreatic elastase 2A and 2B. The sequence of human neutrophil elastase 
(human ELANE) parallels porcine pancreatic elastase (porcine ELS1) with 43% identical 
residues 179. 
ELANE
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ELA3A
ELA3B
ELA2A
ELA2B
Human pancreatic
elastases
Neutrophil elastase
 
Figure I.7: Phylogenetic analysis of coding sequences of human elastases  
The analysis was performed using the Phylogenetic web repeater 121. 
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Figure I.8: Phylogenetic analysis comparing coding sequences of human and porcine 
elastases  
The analysis was performed using the Phylogenetic web repeater 121. 
3.4 FIBROBLAST GROWTH FACTOR-2 
In 1974, the group around Gospodarowicz purified a protein from the bovine pituitary gland. 
Because of its ability to induce proliferation in 3T3 mouse fibroblasts and its basic isoelectric 
point of 9.6, the protein was called basic fibroblast growth factor (bFGF) 77. Later, after more 
members of the FGF family had been found, the proteins were numbered serially and bFGF 
was renamed to FGF-2. To date, 22 members of the human fibroblast growth factor family 
and four major FGF receptor families called FGFR 1 to 4 have been identified 141.  
FGF-2 is a heparin binding growth factor that affects the growth, differentiation, migration 
and survival of a wide variety of cell types. Its sequence is highly homologous across a wide 
range of species 139. Especially the human and the bovine FGF-2 protein are extremely 
homologous; they show an amino acid sequence homology of 98.7% 1. The human and the 
porcine FGF-2 protein are as well highly related. 
FGF-2 has been found in all organs, solid tissues, tumors, and cultured cells examined 165. 
Five different isoforms result from alternative initiations of translation: one AUG-initiated 
isoform of 18 kDa and four CUG-initiated forms of 22, 22.5, 24 and 34 kDa (see Figure I.9). 
Whereas the smaller 18 kDa form is primary localized in the cytosol, the others are 
predominantly found in the nucleus 140. 
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Figure I.9: The five different isoforms of FGF-2 as result of alternative translation 
The green boxes represent the nuclear localization signal. Adapted from Okada-Ban et al., 2000 140. 
3.4.1 FGF-2 secretion 
Known stimuli for the release of FGF-2 are estrogen 5, hypoxia 97, inflammatory cytokines 168, 
thrombin 43, nicotine 44 or elevated hydrostatic pressure 2. Furthermore, it has been 
demonstrated that shear stress is a very potent stimulus for FGF-2 release from smooth 
muscle cells in vitro 182 and endothelial cells in vitro 75 and in vivo 115. The knowledge of how 
cells, especially endothelial cells, sense this physical stimulus and transduce it to a 
biochemical signal represented by FGF-2 release is very limited. Gloe et al. showed that 
blocking the integrin αvβ3 inhibited the shear stress induced FGF-2 release, indicating that this 
integrin is involved in the mechanotransduction process 75. 
FGF-2 lacks a consensus signal sequence for secretion, and is therefore not released via the 
classical protein secretion pathway that progresses through the ER and the Golgi apparatus. 
Initially, it was suggested that it was released as the result of cell damage, cell death and non-
lethal membrane disruptions 45. But as FGF-2 is also released from viable, undamaged cells, a 
secretion via a nonclassical ER/Golgi-independent pathway was suggested eventually 62. 
Other proteins that are unconventionally secreted are fibroblast growth factor-1 (FGF-1), 
interleukin-1α (IL-1α), interleukin-1β (IL-1β) and the galectins 137,157. Yet the molecular 
mechanisms of their secretion process stay elusive. 
The group around Nickel was able to show that FGF-2 membrane translocation occurs in a 
folded conformation 10. Furthermore they proposed that FGF-2 is initially recruited to the 
inner leaflet of plasma membranes followed by membrane translocation via heparan sulfate 
proteoglycans that form an extracellular trap facilitating the export of the growth factor 207. In 
addition, a release via exosomes and vesicles was discussed 33,188. 
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3.4.2 FGF-2 signaling 
Released FGF-2 signals via autocrine and paracrine mechanisms. It interacts with low-affinity 
heparin or heparan sulfate proteoglycans (HSPGs) on the cell surface. This interaction 
protects the growth factor against heat, acid denaturation and protease cleavage and increases 
its affinity to the receptor 40,205. FGF-2 has two separate receptor binding sites which allow 
one FGF-2 molecule to bind two high affinity FGF receptors. Finally two receptors, two 
FGF-2 molecules and two heparan sulfate chains form a ternary FGF-FGFR-HSPG signaling 
complex 123. FGF-2 activation of FGFR induces receptor dimerization and subsequently 
causes an autophosphorylation inside the cells and the initiation of signaling cascades. 
3.4.3 Biological functions of FGF-2 
FGF-2 exerts pleiotropic roles in many cell types and tissues. It stimulates cell migration, cell 
differentiation, cell proliferation and a variety of developmental processes and thereby 
regulates the growth and function of vascular cells. Furthermore, it is involved in 
angiogenesis, arteriogenesis (see chapter I.3.1 and I.3.2) and in the pathogenesis of vascular 
diseases such as atherosclerosis. 
As FGF-2 knockout mice are viable, fertile and phenotypically indistinguishable from their 
wild-type littermates, the protein is not essential for embryonic development. These mice 
furthermore show no morphological defects in heart and vasculature, but exhibit reduced 
blood pressure 50,140, decreased vascular tone 209 and delayed wound healing 143. These 
findings indicate that no vital function is absolutely dependent on FGF-2, which may be due 
to the redundant functions of several FGFs 140. In contrast, FGFR1 and FGFR2 knockout are 
lethal in the embryonic stalk 208. FGF receptor mutations are associated with birth defects 
involving craniosynostosis or skeletal abnormalities 24. 
Clinical application of FGF-2 could be useful to stimulate wound healing and augment 
collateral artery development to relieve myocardial and peripheral ischemia. By contrast, 
FGF-2 inhibition may limit angiogenesis and thus tumor growth or blindness (diabetic 
retinopathy) or the restenosis that often follows vascular interventions such as balloon 
angioplasty 139. 
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4 MECHANOTRANSDUCTION 
4.1 OUTSIDE-IN SIGNALING 
The cellular plasma membrane creates a barrier between the inside and outside of the cell. In 
order to respond to its environment, bidirectional signaling across the plasma membrane is 
mediated by integrins. The transduction of chemical and mechanical signals from the 
extracellular space to the cytoplasm via integrins is called outside-in signaling (see 
Figure I.10) 159. 
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Figure I.10: Integrin outside-in signaling induced by mechanical stress 
 
 
4.1.1 Extracellular matrix 
The extracellular matrix (ECM) is important for the organization of a tissue and the 
connectivity of single cells. Beyond providing mechanical support, it has an active role in 
regulating cell shape, behavior and function 4. The extracellular matrix is a complex 
molecular network of scaffolding elements, a mixture of adhesive glycoproteins, 
glycosaminoglycans and proteoglycans (see Table I.4). These molecules are produced 
intracellularly and continuously secreted into the matrix via exocytosis 123. 
Table I.4: Components of the extracellular matrix 4,7 
Scaffolding elements Glycoproteins Proteoglycans 
Collagen Fibronectin Perlecan 
Elastin Laminin Syndecan 
 Fibrinogen Aggrecan 
 Vitronectin  
 Tenascin  
 Thrombospondin  
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Two biochemically and morphologically different structures of extracellular matrix can be 
separated in the vessel: the basement membrane and the interstitial matrix 81. The basement 
membrane underlies the endothelium. It is composed of type IV collagen fibers, perlecan and 
laminin. The interstitial matrix located in between the cells mainly contains collagens of type 
I, III, V, VI, fibronectin and proteoglycans 112. 
4.1.2 Integrins 
The cells are linked to the extracellular matrix via integrins, a large family of homologous cell 
surface molecules that bind the ECM and therefore are responsible for cell adhesion 4. They 
possess functions in hemostatis (platelet αIIbβ3) 175, leukocyte adhesion (αLβ2, αMβ2) 117, 
inflammation (leukocyte αLβ2 and α4) 181, angiogenesis (endothelial αvβ3) 55, bone resorption 
(osteoclast αvβ3) 189 and cell migration (amongst others α5β1 and αvβ3) 91. 
Integrins are non-covalent bound heterodimers which are composed of an α- and β-subunit. In 
total 18 α- and 8 β-subunits form 24 heterodimers 186. Each subunit contains an extracellular 
domain that interacts with molecular binding sites of the extracellular matrix, a 
transmembrane region, and a short cytoplasmic domain which associates with the actin 
cytoskeleton. Integrins bind extracellular matrix components like laminin, collagen, 
fibronectin, fibrinogen, vitronectin, thrombospondin or other cell adhesion molecules like 
VCAM or ICAM (vascular and intercellular adhesion molecule) 186. These matrix molecules 
can mediate cellular effects via the integrin. Ligand binding induces integrin clustering, which 
results in the formation of highly organized intracellular complexes, known as focal adhesions 
that are connected to the cytoskeleton. This mode of signaling is called integrin outside-in 
signaling 159. Adherent cells need the attachment to the extracellular matrix to proliferate and 
even to survive (anchorage dependence) 4. By contrast, the ability of cells to control integrin 
activity from within is termed inside-out signaling. 
Most integrin outside-in signals depend on the focal adhesion kinase (FAK) and thereby also 
src-family-kinases (SFKs). A subset, including the integrins α1β1, α5β1 and αvβ3, in addition, 
activates the adaptor protein Shc 81,177 (see Figure I.11). 
Shear stress activates endothelial integrins 120,194. Studies of Orr and colleagues showed that 
this integrin activation was specifically dependent on the underlying matrix component. Flow 
induced integrin α2β1 activation in cells on collagen, but not on fibronectin or fibrinogen, 
conversely α5β1 and αvβ3 were activated on fibronectin and fibrinogen, but not collagen 142. 
Shear stress induced integrin activation starts within one minute and lasts for more than six 
hours 120. Blocking integrins using anti-integrin antibodies or inhibitory RGD (arginine-
glycine-aspartic acid) peptides attenuates the shear induced signaling 120. 
The integrin αvβ3, known as vitronectin receptor, mediates the adhesion of cells to vitronectin 
but also to fibronectin and various other ligands 93. Its key recognition motif is composed of 
three amino acids: arginine-glycine-aspartic acid (RGD). The integrin αvβ3 has been reported 
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to be present in focal contacts in endothelial cells 73. This integrin is important for cell 
adhesion and migration, neointima formation, angiogenesis and bone resorption 108,109. It was 
identified as a marker for angiogenic vascular tissues, and its inhibition using RGD peptides 
induced apoptosis 19,20. Furthermore, in collateral vessels the integrin αvβ3 was upregulated in 
the vascular wall, indicating an increased outside-in signaling during arteriogenesis 28. 
The Shc (Src homology 2 domain-containing transforming protein) adaptor protein family 
consists of three members. Whereas ShcA (here named Shc) is ubiquitously expressed, ShcB 
and C appear restricted to neuronal cells 161. It has been shown that shear stress activation of 
the integrin αvβ3 is associated with an increased interaction of the integrin with Shc 36. Jalali et 
al. were able to show that shear stress increased this association only in cells plated on 
fibronectin or vitronectin 98. Furthermore, shear stress induced Shc tyrosine phosphorylation 
and the association of Shc with Grb2 (growth factor receptor-bound protein-2) 36. Docking of 
Shc to integrins is linked to the activation of the MAP kinases ERK, JNK and p38 114. 
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Figure I.11: Integrin signaling pathways 
Integrin signaling affects cell proliferation, survival and migration via ERK, Akt and JNK. Furthermore, 
overexpression of FAK has been shown to activate p38 3. The binding of mechano-sensitive integrins 
to Shc is also linked to the activation of ERK, JNK and p38 114. Adapted from Guo and Giancotti, 
2004 81. 
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4.1.3 Focal adhesions 
Inside the cells, the integrin cytoplasmic domains are clustered in dynamic structures called 
focal adhesions or focal contacts. A mass of proteins including α-actinin, talin, vinculin, 
paxillin, the focal adhesion kinase (FAK) and the integrin-linked kinase (ILK) are involved in 
these points and form discrete subcellular regions where the plasma membrane is in tight 
association with the underlying substrate 70,195. Bundles of actin filaments, called stress fibers, 
terminate and are associated with the plasma membrane at focal adhesion sites. They are 
composed of filaments formed by the contractile interaction of actin, myosin, α-actinin and 
tropomyosin 104. 
The focal adhesion kinase is a cytoplasmatic, non-receptor protein tyrosine kinase. Its 
N-terminal domain binds to sequences in the cytoplasmic domain of β-integrin subunits. The 
C-terminal region is rich in protein-protein interaction sites 146. Cell adhesion or clustering of 
integrins results in a rapid autophosphorylation of FAK at Tyr397, creating a binding site for 
the SH2 domain-containing molecules, such as Src, to be recruited and activated. Interaction 
with Src accelerates FAK phosphorylation at Tyr407, Tyr576/577, Tyr861 and Tyr925. It has 
been suggested that Tyr576/577 phosphorylation elevates the kinase activity of FAK, while 
phosphorylation at Tyr925 confers the site for Grb2 binding which may lead to the activation 
of Ras and triggers the MAP kinase cascade 169. FAK has been shown to be involved in 
arteriogenesis and cancer progression 28,128. 
Shear stress causes a migration and orientation of endothelial cells in flow direction. In this 
process, focal adhesions are redistributed and FAK is recruited to focal adhesions, which is 
accompanied by changes in its phosphorylation 118,163. The redistribution of integrins and 
focal contacts serves to strengthen EC adhesion at the points of greatest stress 12. Thereby the 
cell cytoskeleton components are rearranged and stress fibers assemble 104. 
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Figure I.12: Focal adhesion kinase domain structure and phosphorylation sites  
FAK is composed of a FERM (protein 4.1, ezrin, radixin, moesin homology) homology that can bind 
integrins and growth factor receptors, a central catalytic domain and a FAT (focal adhesion targeting) 
domain, which not only directs FAK to adhesion complexes but also provides binding sites for other 
docking molecules 204. PRR: Proline-rich region. Adapted from Mitra et al., 2005 131. 
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4.2 THE MAP KINASE PATHWAYS 
Mitogen-activated protein kinases (MAPK) are a group of serine/threonine kinases 148. They 
are activated by an enormous array of distinct extracellular stimuli through dual 
phosphorylation at conserved threonine and tyrosine residues by upstream kinases (see Figure 
I.13) 203. Mammals express five different families of MAPK: extracellular signal-regulated 
kinases (ERK1, ERK2), c-Jun N-terminal kinases (JNK1, JNK2, JNK3, also referred to as 
stress-activated protein kinases or SAPKs), p38 kinase isozymes (p38α, p38β, p38γ, p38δ), 
ERK3/4 and ERK5. The first three of the above are known to be implicated in human 
diseases 158. 
Via phosphorylation of numerous proteins, including transcription factors, cytoskeletal 
proteins and kinases, the MAP kinases greatly influence gene expression, metabolism, cell 
division, cell morphology and cell survival 158. 
Shear stress activates multiple signaling pathways that include the different members of the 
MAPK family. ERK, JNK and p38 are all activated but with different temporal patterns 9,99,120. 
Azuma et al. furthermore demonstrated that the shear stress induced p38 activation leads to 
MAPK activated protein kinase 2 (MAPKAP kinase 2) activation followed by 
phosphorylation of heat shock protein 27 (Hsp27) 8,119. 
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Figure I.13: MAPK pathways 
Each MAPK pathway contains three steps comprising a MAP kinase kinase kinase (MAPKKK or 
MEKK), a MAP kinase kinase (MAPKK or MEK) and the MAPK 38. MAPKKK phosphorylates and 
thereby activates MAPKK. Activated MAPKK in turn phosphorylates MAPK 203. Common inhibitors of 
these three pathways are labeled in red. Image modified from Cobb, 1999 38. 
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Heat shock proteins serve as molecular chaperones. They assist in the folding of proteins and 
are able to protect them from damage by environmental factors 60. Furthermore, Hsp27 is 
known to inhibit apoptosis and modulate F-actin polymerization, preventing stress induced 
disruption of the cytoskeleton 39. 
Hsp27 belongs to the family of small Hsps, which range in monomer size from 15 to 30 kDa, 
but form oligomeric complexes of 200 to 800 kDa. Phosphorylation occurs on three different 
serine residues: Ser16, Ser78 and Ser82 and is catalyzed by MAPKAP kinases 2 and 3, which 
are activated through phosphorylation by p38. An enhanced expression and phosphorylation 
of Hsp27 is seen as a response to estrogen 151, different forms of stress such as heat 
shock 111,166, oxidative stress 13 and shear stress 8,119,150, cytokines, thrombin and histamine 116. 
As mentioned earlier, many of those stimuli also lead to a release of FGF-2.  
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Figure I.14: Hsp27 phosphorylation is linked to its function 
P38 phosphorylates MAPKAP kinase 2 and 3 (MAPKAPK 2 and 3), which phosphorylate Hsp27 on 
key serine residues 60. In vitro, the non-phosphorylated form of Hsp27 inhibits actin polymerization, 
whereas the phosphorylated protein allows actin to polymerize 15,80. 
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5 AIM OF THIS STUDY 
Chronic elevation of shear stress stimulates vessel remodeling and adaptation. These events 
require the control of cell proliferation, migration and differentiation, pivotal processes being 
mainly regulated by growth factors such as fibroblast growth factor-2 (FGF-2). Shear stress 
has already been shown to induce the release of FGF-2 from endothelial cells 75. Thus, FGF-2 
release may represent a necessary initial step in the adaptive remodeling process induced by 
shear stress. Our laboratory has demonstrated before that the shear stress-induced release of 
FGF-2 depends on the functional integrin αvβ3 75, and also provided first evidence that a 
serine protease with elastase activity may play a pivotal role in the shear stress-induced 
signaling cascade leading to FGF-2 release 107. Based on these findings, the aims of the 
present study were: 
 
 
1. Functional characterization of the putative elastase mediating the shear stress-induced 
FGF-2 release 
 
We wanted to clarify whether the endothelial enzyme shares substrate specificity with known 
elastases and whether endothelial cells express any of the two known elastases, pancreatic or 
neutrophil elastase. We further aimed to investigate whether this enzyme is stored in 
endothelial cells. Finally, we aimed to analyze the effect of this enzyme on the macrostructure 
and cleavage pattern of defined protein matrices. 
 
 
2. Analysis of the shear stress-induced integrin αvβ3 activation and the role of elastase in 
this process 
 
Since the integrin αvβ3 is involved in the shear stress-induced FGF-2 release, it was further 
aimed to analyze the impact of elastase on integrin αvβ3 outside-in signaling and parameters 
of integrin activation like focal adhesion assembly and reorganization of the cytoskeleton. 
 
 
3. Intracellular signaling pathways and proteins involved in the FGF-2 release process 
 
Based on the earlier demonstration of Christina Klarskov Mogensen of an elastase-mediated 
activation of p38 and Hsp27 107, it was aimed to clarify whether this activation pathway plays 
a role in the shear stress-induced FGF-2 release and whether other MAP kinases are activated 
as well. We also wanted to analyze the role of Hsp27 in the release of FGF-2 by knockdown 
experiments. 
  
 MATERIALS AND METHODS 
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II MATERIALS AND METHODS 
1 MATERIALS 
1.1 REAGENTS 
Reagent Company 
2-Propanol Merck KGaA 
Acetic acid 100% AppliChem GmbH 
Acrylamide 30% (Mix 37.5:1) Genaxxon Bioscience GmbH 
Agarose AppliChem GmbH 
Ammonium hydroxide Sigma-Aldrich Chemie GmbH 
Ammonium persulfate AppliChem GmbH 
Aprotinin AppliChem GmbH 
Aqua ad iniectabilia B. Braun Melsungen AG 
Boric acid AppliChem GmbH 
Bromophenol blue Sigma-Aldrich Inc. 
Bovine serum albumin (albumin fraction V) AppliChem GmbH 
Bovine serum albumin (acetylated) Aurion 
Calcium chloride Sigma-Aldrich Chemie GmbH 
Coomassie brilliant blue G-250 AppliChem GmbH 
Dimethyl sulfoxide AppliChem GmbH 
Disodium ethylenediaminetetraacetic acid AppliChem GmbH 
Disodium hydrogen phosphate dihydrate AppliChem GmbH 
Ethanol Merck KGaA 
Ethidium bromide Sigma-Aldrich Inc. 
Ficoll-Paque Plus GE Healthcare 
Formaldehyde 37% AppliChem GmbH 
Glutaraldehyde Calbiochem 
Glycerol AppliChem GmbH 
Glycine AppliChem GmbH 
Heparinase I 
(from Flavobacterium heparinum) 
Sigma-Aldrich Inc. 
Hydrochloric acid Merck KGaA 
Leupeptin AppliChem GmbH 
Magnesium chloride Fluka Chemie AG 
Methanol AppliChem GmbH 
Nonfat dried milk powder AppliChem GmbH 
Paraformaldehyde Merck KGaA 
Phenylmethylsulfonyl fluoride Sigma Aldrich Chemie GmbH 
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Potassium chloride Merck KGaA 
Potassium dihydrogene orthophosphate Merck KGaA 
Saponin Sigma-Aldrich Inc. 
Sodium azide Sigma-Aldrich Chemie GmbH 
Sodium chloride AppliChem GmbH 
Sodium deoxylcholate AppliChem GmbH 
Sodium dodecylsulfate AppliChem GmbH 
Sodium fluoride Merck KGaA 
Sodium hydroxide AppliChem GmbH 
Sodium orthovanadate Alexis Corporation 
Tetramethylethylenediamine AppliChem GmbH 
Tris AppliChem GmbH 
Triton X-100 AppliChem GmbH 
Tween 20 AppliChem GmbH 
Uranly acetate Merck KGaA 
Xylene cyanol Sigma-Aldrich Inc. 
β-Mercaptoethanol AppliChem GmbH 
 
Unless stated otherwise, all buffers were prepared using deionized water. If necessary, pH 
was adjusted by addition of hydrochloric acid or sodium hydroxide solutions, respectively. 
1.2 TECHNICAL EQUIPMENT 
Flow cytometer FACSort (Becton Dickinson) 
Confocal laser scanning microscope Leica TCS SP5 (Leica Microsystems) 
Fluorescence microscope Axiovert 200M (Carl Zeiss) 
Axiophot (Carl Zeiss) 
equipped with a AxioCam MRm (Carl Zeiss) 
Imaging system for western blot analysis 
(CCD camera) 
Digital CCD Camera (ORCA-ER) 
(Hamamatsu Photonics) 
Thermocycler for real time PCR Light Cycler 1.5 (Roche) 
Thermocycler for PCR Mastercycler ep gradient S (Eppendorf AG) 
Table centrifuge for microcentrifuge tubes EBA 12 (Hettich Zentrifugen) 
Cooling centrifuge for microcentrifuge tubes Biofuge Primo R (Heraeus Instruments) 
Cooling centrifuge for falcon tubes Megafuge 1.0R (Heraeus Instruments) 
ELISA plate reader Infinite F200 (Tecan) 
Cell counter Coulter AcT 8 (Beckman Coulter) 
PH measurement PHM 82 Standard pH Meter  
(Radiometer Copenhagen) 
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1.3 CELL CULTURE 
All sterile work was performed using an air flow work bench (LaminAir HB2448, Heraeus 
Instruments). Before usage, all instruments were autoclaved by means of a steam sterilizer 
(H&P Labortechnik AG). The cells were cultivated in a humidified incubator (Sanyo CO2 
Incubator Model MCO-17AI, Sanyo Electric Co. Ltd.) at 37°C and aerated with 5% of carbon 
dioxide. To control cell appearance and behavior, a light microscope (Fluovert FU, Leitz) was 
used. 
Cell culture reagents and tools Company 
Accutase PAA Laboratories GmbH 
Antibiotic antimycotic solution 
(Amphotericin B, Penicillin, Streptomycin) 
Sigma-Aldrich Chemie GmbH  
Cell culture dishes, 6 and 24 well plates BD Biosciences (BD Falcon) 
Collagen G Biochrom AG 
Collagenase A Roche 
Cryovials Biozym Scientific GmbH 
Dulbecco’s Modified Eagle Medium Gibco Invitrogen 
Dulbecco’s Modified Eagle Medium 
without phenol red 
Sigma-Aldrich Chemie GmbH 
Endothelial Cell Growth Medium Promocell 
Fetal calf serum Biochrom AG 
Fibronectin Harbor Bio-Products 
Hank’s balanced salt solution Apotheke Innenstadt, University-Clinic of 
Munich 
L15 Medium (Leibovitz) Sigma-Aldrich Inc. 
Supplement Mix Promocell 
Trypsin-EDTA solution Sigma-Aldrich Chemie GmbH 
 
Fetal calf serum (FCS) was heat inactivated at 56°C for 30 minutes and stored at 20°C. In cell 
culture, two sterile phosphate buffers were used, one without calcium and magnesium ions 
(PBS-), the other one containing these ions (PBS+) (see composition below). These buffers 
were either prepared in the laboratory or obtained from the local dispensary (Apotheke 
Innenstadt, University-Clinic of Munich). 
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PBS (pH 7.4)  PBS Ca2+/Mg2+ (pH 7.4) 
NaCl 137 mM  NaCl 137 mM 
KCl 2.68 mM  KCl 2.68 mM 
Na2HPO4 8.1 mM  Na2HPO4 8.1 mM 
KH2PO4 1.47 mM  KH2PO4 1.47 mM 
in Aqua ad iniectabilia    MgCl2 0.42 mM 
    CaCl2 0.90 mM 
    in Aqua ad iniectabilia  
 
 
1.3.1 Isolation of primary endothelial cells 
1.3.1.1 PAEC – Porcine aortic endothelial cells 
All experiments were performed using endothelial cells from pig aortas (PAEC – porcine 
aortic endothelial cells). The isolation of these cells has been described previously by 
Gloe et al. 74. 
The aortas were obtained directly from the local slaughterhouse. After washing them several 
times with sterile PBS+, surplus fat and connective tissue were removed. Subsequently, the 
aortas were sliced lengthwise and clamped in specially-designed metallic frames. The inner 
surface of the vessel was covered with 2 ml of a collagenase A solution (1 mg/ml, 
activity > 0.15 U/mg) at 37°C for 1 hour, leading to the dissolution of the endothelial cells. 
They were scraped off and cultivated in PAEC growing medium in the incubator at 37°C in 
standard plastic culture dishes. After reaching confluence, cells were frozen and thawed when 
needed (see chapter II.1.3.3). 
PAEC growing medium    PAEC starving medium   
FCS 10 %  FCS 1 % 
Antibiotic antimycotic solution 1 %  Antibiotic antimycotic solution 1 % 
in DMEM    in DMEM  
 
 
1.3.1.2 HUVEC – Human umbilical vein endothelial cells 
Human umbilical cords were kindly provided by the gynecological hospital of the Ludwig-
Maximilians-Universität Munich (Campus Innenstadt and Großhadern). 
The central vein in the umbilical cords was rinsed with PBS+ and incubated with a 
collagenase A solution (1 mg/ml, activity > 0.15 U/mg) for 10 minutes at 37°C. Then the 
dissolved primary endothelial cells were washed out with warm HUVEC growing medium 
(a 1:1 mixture of HUVEC growing medium I and II), centrifuged at 1,200 x G for 5 minutes 
and cultivated in standard plastic culture dishes in the incubator at 37°C. 
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HUVEC growing medium I    HUVEC growing medium II   
FCS 20 %  Supplement Mix 2.5 % 
Antibiotic antimycotic solution 1 %  in Endothelial Cell Growth Medium  
in DMEM      
 
 
1.3.2 Cell passaging 
Cells were subcultured at 90 to 100% confluence. After washing the cells with PBS-, a 
solution containing 0.5% trypsin and 0.2% EDTA was added (1 ml per 78.2 cm² flask). Due 
to the proteolytic activity of trypsin and the ability of EDTA to catch bivalent cations as a 
chelating agent, adherent cells detach from the culture dish. This process, which was observed 
using the light microscope, takes 5 to 10 minutes at 37°C. Detached cells are characterized by 
a rounded cell shape. To inactivate trypsin, 5 ml of PAEC or HUVEC growing medium, 
which both contain at least 10% of serum, were added. This cell solution was then diluted by 
adding the required volume of growing medium. Depending on the planned experiment and 
the required cell confluency dilutions in a ratio of 1:2 to 1:4 were used. Subsequently, the 
cells were cultivated in growing medium. For all experiments PAEC of passage 2 to 5 and 
HUVEC of passage 1 to 2 were used. 
1.3.3 Freezing and thawing 
For long-time cell storage, cells were frozen. For this purpose, endothelial cells were 
incubated with trypsin for approximately 2 to 5 minutes, centrifuged and resupended in a 
respective amount of freezing medium. Afterwards, cell solutions were added to cryovials, 
frozen for 24 hours at -80°C and thereafter stored for preservation in liquid nitrogen (-196°C). 
Freezing medium 
DMSO 10 % 
in FCS   
 
Cells were quickly defrosted in a water bath. Subsequently, they were added to plastic culture 
dishes containing growing medium of 37°C and placed in the incubator. After 24 hours, cells 
were subcultured. 
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1.4 ISOLATION OF LEUKOCYTES FROM HUMAN AND PORCINE BLOOD 
As a positive control for neutrophil elastase, mononuclear cells were isolated from human and 
porcine blood. For this purpose, 4 ml Ficoll-Paque were carefully covered with 5 ml of the 
blood sample containing the anticoagulant heparin (Heparin-Natrium-25000-ratiopharm, 
Ratiopharm). The falcon tube containing these two layers was centrifugated for 12 minutes at 
1,400 x G and 8°C without using the centrifuge brake. The emerging layer between plasma 
and Ficoll-Paque (see Figure II.1), called buffy coat, was removed with a pasteur pipette and 
collected in another tube. This cell solution was centrifuged for 10 minutes at 1,000 x G. 
Afterwards, the cell pellet was lysed and used for protein or RNA analysis. 
 
Figure II.1: Ficoll gradient centrifugation for white blood cell isolation 
The buffy coat containing the mononuclear cells (here in light red) was isolated via Ficoll centrifugation. 
1.5 PREPARATION OF HUMAN AND PORCINE PANCREATIC TISSUE 
Human pancreas was provided by the University-Clinic of Munich (Foundation HTCR – 
Human tissue and cell research). Porcine pancreas was obtained directly from the Walter-
Brendel-Centre of Experimental Medicine (Munich). 
The frozen pancreatic tissue was added to a mortar in a box filled with dry ice. Liquid 
nitrogen was poured rapidly into the mortar and the pancreas was mechanically grinded with a 
pestle until pulverized. Subsequently, the powder was lysed for protein or RNA analysis. 
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2 METHODS 
2.1 CELL STIMULATION AND INHIBITION 
2.1.1 Shear stress 
2.1.1.1 Cone and plate apparatus 
For shear stress application, a self-made cone and plate apparatus was used (see scheme and 
photograph in Figure II.2).  
 
 
 
 
 
Figure II.2: Cone and plate apparatus 
 
 
Shear stress was adjusted using the following equation: 
μωτ = α   
τ: shear stress [N · m-²] [1 N = 105 dyn] 
μ:  viscosity of the medium [N · s · m-2] 
ω: angular velocity [s-1] 
α: angle of the cone 
 
 
 
Unless stated otherwise, glass plates, measuring 10 cm in diameter, were coated with 
collagen G (10 µg/ml), which mainly consists of collagen type I. Some additional experiments 
were performed using fibronectin (10 µg/ml) as coating agent. Confluent cells were 
transferred in a 1:1 ratio from 10 cm plastic culture dishes onto these glass plates, which were 
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placed in plastic petri dishes (Greiner Bio-One). The cells were left in PAEC growing 
medium overnight (24 h) until they reached confluency. 30 minutes prior to the planned 
experiments, the medium was changed to 7 ml of PAEC starving medium (without phenol 
red). After this time, one of the glass plates was put in the metal cylinder of the shear stress 
apparatus and covered with the pre-used 7 ml of starving medium. Now the metal cylinder 
was inserted into the apparatus, the cone was lowered and a shear stress of 16 dyn per cm² 
was applied. By modification of the angular velocity of the cone, a particular shear stress was 
applied. Another glass plate, which was left in the petri dish as a control, was put in the same 
incubator. After 2 hours of stimulation with shear stress, cell supernatants were collected, 
centrifuged for 5 minutes at 1,200 x G and frozen for storage. The cells were rinsed with 
PBS- and 1 ml of lysis buffer was added. These samples were frozen as well. For western blot 
analysis of elastase and von Willebrand factor in cell supernatants, they were concentrated in 
a 1:10 ratio using centrifugal columns (Vivaspin 4, 10,000 MWCO, Sartorius Stedim Biotech). 
2.1.1.2 Parallel plate apparatus 
For immunofluorescence experiments a parallel plate apparatus (see Figure II.3) was used for 
shear stress experiments. This system consists of a pump (Ismatec IPS-12, Ismatec SA) 
connected to tubes and a µ-slide from Ibidi. The pump presses the medium through the tubes 
and the slide. During the experiment the slides were placed onto a 37°C heating plate.  
Prior to the planned experiment, the uncoated slide was incubated for 30 minutes with 
collagen G (10 µg/ml). Afterwards it was rinsed with 1 ml of Aqua ad iniectabilia and left 
under the bench until completely dry. Next, 100 µl cell suspension containing approximately 
30,000 cells was filled into the slide. Subsequently, the slide was incubated at 37°C. After cell 
attachment, the two reservoirs of the slide were each filled with 500 µl PAEC growing 
medium. When the cells were confluent, L15 medium was used, since these shear stress 
experiments were performed outside a CO2 incubator. This medium is buffered by salts, free 
amino acids and galactose, preserving a physiological pH. The slide was connected to the 
tubes of the flow apparatus and a shear stress of 16 dyn per cm² was applied, corresponding to 
a flow of 12.8 ml per minute. The calculation was performed using the equation below 64. 
After applying shear stress, the cells were prepared for fluorescence microscopy as described 
in chapter II.2.7.3. Finally, cells were mounted using the Vectashield mounting medium 
(Vector Laboratories) and analyzed by confocal laser scanning microscopy. 
 
2
6μQτ = 
bh
 
 τ:  shear stress [dyn · cm-2] 
μ:  viscosity [0.01 dyn · s · cm-2]  
Q:  flow rate [0.213 cm3 · s-1] 
b:  channel with [0.5 cm]  
h:  channel height [0.04 cm] 
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Figure II.3: Parallel plate apparatus 
 
 
2.1.2 Stimulation with porcine pancreatic elastase 
Porcine pancreatic elastase (Serva Electrophoresis GmbH) was diluted in a concentration of 
1 mg/ml in Tris buffer (10 mM, pH 8.5). According to the manufacturer’s information, 1 mg 
enzyme had an activity of 232 units. 1 unit is defined as the amount of enzyme that catalyzes 
the hydrolysis of 1 µmol N-acetyl-L-alanyl-L-alanyl-L-alanine methyl ester per minute at 
25°C and pH 8.5. Confluent cells were rinsed twice with PBS+. Then Hank’s balanced salt 
solution was added for 2 hours at 37°C (drying cabinet). Since Hank’s solution does not 
contain FCS, and thus no growth factors, cells should synchronize their cell cycle during this 
time. Cells were stimulated with 0.5 U/ml of elastase, according to findings of Klarskov 
Mogensen 107. Incubation time depended on the type of experiment (5, 10, 30 or 60 minutes). 
In cases where the cell supernatants were needed for further experiments, they were collected. 
Afterwards the cells were washed with PBS- and ice-cold lysis buffer was added (1 ml per 
10 cm dish, 200 µl per 6 well). 
Hank’s balanced salt solution (pH 7.4) 
NaCl 8 g 
KCl 0.4 g 
MgSO4 x 7 H2O 0.13 g 
MgCl2 x 6 H2O 0.07 g 
CaCl2 x 2 H2O 0.13 g 
Na2HPO4 x 2 H2O 0.15 g 
KH2PO4 0.06 g 
Glucose x H2O 0.06 g 
NaHCO3 0.3 g 
in Aqua ad iniectabilia ad 1,000 ml 
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2.1.3 Inhibition 
Inhibition of elastase, integrin or MAPK activity was performed by applying the particular 
inhibitor (see Table II.1). In shear stress as well elastase treatment experiments, inhibitors 
were added to the culture dish 30 minutes prior to beginning the stimulation. The 
concentrations mentioned in Table II.1 were used. 
Table II.1: Inhibitors 
Inhibitor Concentration Target Company 
MeOSuc-Ala-Ala-Pro-
Val-chloromethylketone 
50 µM Neutrophil elastase 180 Bachem AG 
Chymostatin 10 µg/ml Serine and cysteine proteases 
chymotrypsin, chymase, cathepsin 
A, B, C, G, H, L, neutrophil and 
pancreatic elastase 171 
Sigma-Aldrich Inc. 
Abciximab 1 µg/ml Integrin αvβ3, platelet integrin αIIbβ3 
(GpIIb/IIIA) 187 
Lilly 
SB202190 10 µM P38 MAPK Upstate 
U0126 10 µM MEK1, MEK2 Calbiochem 
SP600125 10 µM JNK1, JNK2, JNK3 Calbiochem 
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Figure II.4: MeOSuc-Ala-Ala-Pro-Val-chloromethylketone 
 
 
2.2 CELL TRANSFECTION 
2.2.1 Gene silencing by RNA interference 
RNA interference (RNAi, RNA silencing), a natural process in eukaryotes, is a phenomenon 
that leads to post-transcriptional gene silencing. It is based on the fact that double-stranded 
RNA induces the suppression of specific genes that contain a complementary sequence. The 
mechanism of RNAi was discovered by Andrew Z. Fire and Craig F. Mello in Caenorhabditis 
elegans 61. For this finding they received the Nobel Prize in Physiology or Medicine in 2006. 
Double-stranded RNA (dsRNA) is recognized and cleaved by the enzyme Dicer. The 
resulting small double-stranded RNAs, called small interfering RNAs (siRNA), are 21 to 23 
base pairs in length and have a single stranded 3’ overhang of 2 nucleotides on either end. The 
siRNA is integrated in the RNA-induced silencing complex (RISC), a riboprotein complex. 
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After that, the sense strand of the siRNA is eliminated and the now activated RISC is able to 
bind and cleave mRNA containing a complementary sequence.  
siRNA liposomes
dsRNA
siRNA
Dicer (ATP-dependent)
RISC formation
Association with target mRNA
Sequence-specific mRNA degradation
Endocytosis
 
Figure II.5: RNA interference 
SiRNA containing liposomes are able to cross the cell membrane. After incorporation into the RISC 
complex, the siRNA mediates target sequence specificity for subsequent mRNA cleavage. 
2.2.1.1 Cell transfection with synthetic siRNA 
To induce Hsp27 gene silencing, synthetic siRNA against porcine Hsp27 (Eurofins MWG 
GmbH) was transferred into PAEC using the HiPerFect Transfection Reagent from Qiagen. 
For this purpose, PAEC were seeded onto 6 well plates. After 8 hours and 50 to 80% cell 
confluency, siRNA at concentrations of 5, 20 or 50 nM plus the required amount of HiPerFect 
reagent were added. The reagent contains a lipid that enables an effective siRNA uptake. 
After 24 or 48 hours cells were lysed. Knockdown efficiency was controlled by analyzing the 
samples with western blot (see chapter II.2.6.3). Best Hsp27 downregulation was observed at 
siRNA concentrations of 20 nM and incubation times of 48 h. Therefore silencing 
experiments were always performed for 48 hours using 20 nM of Hsp27 and control siRNA. 
To measure the changes in FGF-2 release induced by Hsp27 knockdown, cells were 
transfected and stimulated with elastase (see chapter II.2.1.2). Cell supernatants were 
collected for FGF-2 determination (see chapter II.2.3). To ensure Hsp27 protein 
downregulation cells were always lysed and analyzed via western blotting. 
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Table II.2: Sequences of Hsp27 and control siRNA 
siRNA Sequence 
Hsp27 siRNA Sense 
Antisense 
GGAUGAGCACGGCUUCAUU 
AAUGAAGCCGUGCUCAUCC 
Control siRNA Sense 
Antisense 
UUCUCCGAACGUGUCACGU 
ACGUGACACGUUCGGAGAA 
 
 
2.3 QUANTITATIVE FGF-2 DETERMINATION 
The concentration of FGF-2 in the supernatant was measured using a sandwich ELISA kit for 
quantitative FGF-2 determination (Quantikine bFGF ELISA, provided by R&D Systems) 
according to the manufacturer’s instructions. The absorbance was measured at 450 nm 
(reference wavelength 550 nm). 
2.4 QUANTITATIVE ELASTASE DETERMINATION 
Quantitative measurement of elastase activity in cell supernatants was performed using 
methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroaniline (MeOSuc-Ala-Ala-Pro-Val-pNA, Bachem 
AG), a specific substrate for neutrophil and porcine pancreatic elastase 32,134. The rate of 
enzymatic hydrolysis was monitored by the increase in absorbance due to the release of the 
yellow reaction product p-nitroaniline.  
The substrate peptide was dissolved in 50% ethanol (20 µg/µl). A calibration curve was 
generated using porcine pancreatic elastase in 8 different concentrations (0, 0.072, 0.145, 
0.290, 0.580, 1.160, 2.320, 4.640 U/ml). 50 µl of each sample and standard solution were 
pipetted into a 96 well plate. To each well 1 µl of the substrate solution was added. The plate 
was then incubated for 30 minutes at 37°C. The absorbance was measured at 405 nm 
(reference wavelength 620 nm) using an ELISA plate reader system (Infinite F200, Tecan). 
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Figure II.6: MeOSuc-Ala-Ala-Pro-Val-pNA 
 
 
2.5 QUANTITATIVE DETERMINATION OF VWF 
The Imubind vWF ELISA kit (American Diagnostica Inc.) was used for quantification of 
vWF in cell supernatants. Since this assay did not recognize porcine vWF, it was performed 
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with supernatants from HUVEC according to the manufacturer’s instructions. The absorbance 
was measured at 450 nm. 
2.6 PROTEIN BIOCHEMISTRY 
2.6.1 Sample preparation 
Cells were rinsed with PBS+ and lysis buffer was added (1 ml per 10 cm dish, 200 µl per 6 
well). After an incubation period of 10 minutes at 4°C, the lysed cells were scraped off the 
culture dish with a rubber policeman and transferred into a microcentrifuge tube. Soluble cell 
fragments were chopped and dissolved using an insulin syringe (BD MicroFine 0.30 x 8 mm 
1 ml U-40, Becton Dickinson). Non-soluble fragments were removed by centrifugation at 
15,000 x G at 4°C for 10 minutes. The supernatant was collected and, if not used right away, 
was stored at -20°C. 
Lysis buffer (pH 7.4)   
Tris 20  mM 
NaCl 137  mM 
EDTA pH 8.0 2  mM 
Glycerol 10 % 
Sodium deoxylcholate 0.1 % 
Aprotinin 10  µg/ml 
Leupeptin 10  µg/ml 
PMSF 1  mM 
NaF 0.5  mM 
Na3VO4 0.5  mM 
 
Prior to each experiment, a stock solution of the lysis buffer was prepared. Sodium 
deoxylcholate was used as detergent. The inhibitors, namely aprotinin, leupeptin, 
phenylmethylsulfonyl fluoride (PMSF), sodium fluoride and sodium orthovanadate, were 
always freshly added to this buffer. Aprotinin acts as inhibitor of serine proteases, while 
leupeptin and PMSF additionally block cysteine proteases. Sodium fluoride inhibits 
phosphatases, while orthovanadate specifically inhibits tyrosine phosphatases. 
Sodium orthovanadate needs to be activated before its usage. Therefore a 200 mM solution of 
Na3VO4 was adjusted to a pH of 10.0. The resulting yellow solution was boiled until colorless. 
After cooling the solution to room temperature, the pH was readjusted. Subsequently, the 
solution was boiled again. This procedure was repeated until the solution stayed uncolored at 
room temperature. Aliquots were stored at -20°C. 
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2.6.1.1 Isolation of the extracellular matrix 
For ECM isolation cells were treated and stimulated as described above and lysed with a 
solution containing 0.1% Triton X-100, 0.1 M NH4OH and 1 mM PMSF 18. After 3 minutes 
of incubation, the lysed cell solution was collected. The ECM which was left on the culture 
dish was washed 4 times with PBS- and sample buffer (4x) was added. Subsequently, the 
ECM was scraped off the culture dish using a rubber policeman. 
Cell dissolving buffer   
Triton X-100 0.1 % 
NH4OH 0.1 M 
PMSF 1 mM 
 
 
2.6.2 Protein quantification 
To determine the quantitative amount of protein in the samples, the bicinchoninic acid assay 
(BCATM Protein Assay Reagent A/B, Perbio) was performed. This method is based on the fact 
that under alkaline conditions bivalent cuprous ions react with proteins resulting in 
monovalent copper (biuret reaction). These reduced cuprous cations are able to react with two 
molecules of bicinchoninic acid producing a purple-colored end product. The amount of the 
resulting complex is proportional to the protein present. 
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(bicinchoninic acid) BCA-copper-complex  
Figure II.7: The reaction of BCA with cupric ion 
Reaction of two molecules BCA and one Cu+-ion forming a purple colored complex 
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To establish the calibration curve, a 0.2% solution of bovine serum albumin (BSA, 2 mg/ml) 
was used. According to the manufacturer’s instructions, the protein standards as well as the 
samples were incubated for 30 minutes at 37°C with the BCA reagent in 96 well plates 
(Corning Incorporated). The calibration curve was measured in duplicate, every sample in 
triplicate. The absorbance of the emerging BCA-complex was determined at 550 nm. 
2.6.3 Western blotting 
2.6.3.1 One dimensional gel electrophoresis 
The sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-Page) is a method to 
separate proteins depending on their molecular mass in an electric field. For small gels the 
Mighty Small II SE 250/SE 260 mini vertical unit from Amersham Biosciences was used. 
Large gels were prepared with the SE 600 Series Electrophoresis Unit from Hoefer. 
Depending on the size of the gel, 10 µg or 40 µg of protein were mixed in a 4:1 ratio with 
sample buffer (4x) and heated to a temperature of 95°C for 5 minutes. The sample buffer 
contains the anionic tenside sodium dodecylsulfate which destroys the secondary and tertiary 
protein structure and inhibits protein-protein interactions, causing the formation of negatively 
charged SDS-protein complexes with constant charge to mass ratios. This means that a 
negative charge is applied to each protein in proportion to its mass. Additionally, 
β-mercaptoethanol disrupts disulfide bonds. The denatured protein samples were applied onto 
a polyacrylamide gel containing a separating and a stacking gel part. This gel electrophoresis 
method refers to the discontinuous system of Laemmli 110.  
Proteins move slower in gels with high percentages of acrylamide. Therefore the 
concentration of acrylamide in the separation gel was chosen depending on the molecular 
weight of the respective protein (see Table II.3). The stacking gel always contained 4% of 
acrylamide. 
For gel polymerization, ammonium persulfate (APS) was needed as initiator for gel formation 
and N,N,N',N'-tetramethylethylenediamine (TEMED) was used as catalyst. After adding the 
electrophoresis buffer to the separation unit, voltage was applied (Power Pack P25, Biometra, 
voltage maximum capacity, current: 20–35 mA). Thus the negatively charged SDS-protein 
complexes migrate to the anode. Smaller proteins migrate faster than larger ones. To 
determine molecular masses, a molecular weight marker (PageRulerTM Prestained Protein 
Ladder, Fermentas) with colored proteins of a certain molecular mass was also added to the 
gel. 
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Sample buffer 4x   
Tris (pH 6.8) 250 mM 
SDS 8 % 
Glycerin 40 % 
Bromophenol blue 0.02 % 
β-Mercaptoethanol 400 mM 
 
Table II.3: Acrylamide concentrations in the separating gel 
Protein Separating gel concentration 
FAK, fibronectin, laminin, vWF 7 % 
ERK, ILK, JNK, p38, Shc, vitronectin 10 % 
Elastase, Hsp27 12 % 
 
Separating gel 12%    Stacking gel 4%   
Acrylamide/Bis-Acrylamide 
30%/0.8% (w/v) 
40 %  Acrylamide/Bis-Acrylamide 
30%/0.8% (w/v) 
13 % 
Tris (pH 8.8) 375 mM  Tris (pH 6.8) 125 mM 
SDS 0.1 %  SDS 0.1 % 
APS 0.05 %  APS 0.05 % 
TEMED 0.05 %  TEMED 0.1 % 
 
Electrophoresis buffer   
Tris 124 mM 
Glycin 960 mM 
SDS 0.5 % 
 
 
2.6.3.2 Semi-dry blotting 
To transfer proteins from polyacrylamide gels to a nitrocellulose membrane, the semi-dry 
blotting method was performed. Therefore a self-made blotting unit was used. The membrane 
(Nitrocellulose Blotting Membran, Peqlab Biotechnologie GmbH) and two sheets of blotting 
paper (Gel Blotting Papier, Schleicher & Schuell BioScience GmbH) were trimmed to the 
size of the gel. The blotting unit as well as the membrane and the filter paper were 
moisturized with transfer buffer. Then the following setup was used: 
Cathode 
Soaked blotting paper 
Gel 
Membrane 
Soaked blotting paper 
Anode 
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A current was applied (voltage maximum capacity, current [mA]: area [cm²] x 0.8). Again, 
the negatively charged SDS-protein complexes move towards the positive pole. Thereby they 
migrate out of the gel into the membrane. Blotting time depended on the molecular weight of 
the protein and therefore varied from 1 to 3 hours. Next, the membrane was blocked for 
1 hour under gentle agitation using 5% skimmed milk powder in TBS-Tween (TBS-T). 
Transfer buffer   
Glycin 39 mM 
Tris 48 mM 
SDS 0.037 % 
Methanol 10 % 
 
TBS-T (pH 7.5)   
Tris 50 mM 
NaCl 150 mM 
Tween 20 0.1 % 
 
 
2.6.3.3 Detection 
The membrane was incubated with the respective antibody solution overnight at 4°C under 
gentle agitation. The antibody was either dissolved in TBS-T buffer with skimmed milk or 
albumin (BSA) using the dilution mentioned in Table II.4. 
After removal of the first antibody, the membrane was washed 3 times for 5 minutes with 
TBS-T buffer. Then the horseradish peroxidase-labeled secondary antibody was added. The 
membrane was incubated for 1.5 hours at room temperature under gentle agitation. 
After again washing 3 times for 5 minutes, the protein was detected using a 
Chemiluminescence Detection Kit for Horseradish Peroxidase (AppliChem GmbH), which is 
a luminol-based substrate. This kit includes two solutions, one containing luminol the other 
stable peroxide. These two were mixed in a 1:1 ratio. When incubating the blot with the 
mixture, the enzyme horseradish peroxidase catalyzes the decomposition of hydrogen 
peroxide. Luminol oxidation creates an exitated state, releasing photons of light when 
decaying to ground state. The appearing luminescence was visualized with the Digital CCD 
Camera from Hamamatsu Photonics, connected to a computer equipped with the Wasabi 
imaging software (Hamamatsu Photonics). 
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Table II.4: Primary antibodies for western blotting 
Antigen MW [kDa] Isotype Dilution Provider and 
product number 
FAK 125 Mouse monoclonal 
IgG1 
1:200 
3% milk powder 
Santa Cruz 
sc-1688 
Fibronectin 220 Rabbit polyclonal 
Ig fraction of antiserum 
1:200 
5% BSA 
Dako 
A0245 
GAPDH 36 Mouse monoclonal 
IgG1 
1:1,000 
5% BSA 
Chemicon 
MAB374 
Hsp27 27 Rabbit polyclonal IgG 1 :1,000 
3% milk powder 
Upstate 
06-478 
Laminin ~ 200/400 Rabbit polyclonal 1:1,000 
5% BSA 
Sigma-Aldrich Inc. 
L9393 
Neutrophil elastase 
(antibody No.1) 
29 Mouse monoclonal 
IgG1 
1:200 
3% milk powder 
Santa Cruz 
sc-53388 
Neutrophil elastase 
(antibody No. 2) 
29 Mouse monoclonal IgM 1:200 
3% milk powder 
Santa Cruz 
sc-59335 
P38 MAPK 
 
38 Rabbit monoclonal IgG 1:1,000 
5% BSA 
Cell Signaling 
9212 
Pancreatic elastase 28 Rabbit IgG 1:1,000 
3% milk powder 
Rockland 
200-4168 
Phospho-FAK 
(Tyr397) 
125 Rabbit polyclonal IgG 1:1,000 
5% BSA 
Calbiochem 
341292 
Phospho-FAK  
(Tyr576/577) 
125 Rabbit polyclonal 1:1,000 
5% BSA 
Cell Signaling 
3281 
Phospho-FAK 
(Tyr925) 
125 Rabbit polyclonal 1:1,000 
5% BSA 
Cell Signaling 
3284 
Phospho-Hsp27 
(Ser82) 
27 Rabbit polyclonal 1 :1,000 
5% BSA 
Cell Signaling 
2401 
Phospho-p38 MAPK 
(Thr180/Tyr182) 
38 Rabbit monoclonal IgG 1:1,000 
5% BSA 
Cell Signaling 
9215 
Phospho-p44/42 MAPK 
(Thr202/Tyr204) 
42/44 Mouse monoclonal 
IgG1 
1:2,000 
5% BSA 
Cell Signaling 
9106 
Phospho-SAPK/JNK 
(Thr183/Tyr185) 
46/54 Rabbit monoclonal IgG 1 :1,000 
5% BSA 
Cell Signaling 
4671 
Shc 46/52/66 Rabbit polyclonal IgG 1:1,000 
3% milk powder 
Upstate 
06-203 
β-tubulin 55 Mouse monoclonal 
IgG1 
1:10,000 
5% BSA 
Sigma-Aldrich Inc. 
T4026 
Vitronectin 65/75 Rabbit polyclonal IgG 1:200 
5% BSA 
Santa Cruz 
sc-15332 
vWF 270 Rabbit, IgG fraction of 
antiserum 
1:100 
5% BSA 
Sigma-Aldrich Inc. 
F3520 
 
Table II.5: Secondary antibodies for western blotting 
Antibody Dilution Provider 
Goat anti-rabbit IgG, HRP conjugate 1:5,000 in 5% milk powder Calbiochem 
Goat anti-mouse IgG, HRP conjugate 1:5,000 in 5% milk powder Calbiochem 
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Figure II.8: Luminol chemiluminescence reaction 
 
 
2.6.3.4 Membrane stripping 
The removal of primary and secondary antibodies from a western blot membrane is called 
stripping. When using one membrane for more than one antigen detection, it is useful to 
remove the already bound interfering antibodies. For this purpose, the membrane was 
incubated for 1 hour at room temperature with the stripping solution mentioned below. 
Stripping buffer (pH 2.8) 
Glycine 0.2 M 
NaCl 0.5 M 
 
 
2.6.4 Unspecific protein detection 
Coomassie brilliant blue stains proteins because it accumulates at their basic side chains. This 
method was used to investigate the degradation properties of elastase on different 
extracellular matrix proteins (see Table II.6). 
The extracellular matrix proteins mentioned in the table below were incubated for 1 hour at 
37°C with 0.5 or 2.5 U/ml of porcine pancreatic elastase. Next, a SDS-Page as described in 
chapter II.2.6.3.1 was performed. Therefore 90 µl of each solution were mixed with 30 µl of 
the sample buffer. The polyacrylamide gel was incubated with the Coomassie staining 
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solution under agitation overnight. The following day, the gel was destained with a solution of 
10% acetic acid. After around 4 hours blue protein bands were observed. 
Coomassie staining solution 
Coomassie brilliant blue 0.7 mM 
Acetic acid 10 % 
2-Propanol 25 % 
 
Table II.6: Extracellular matrix proteins 
ECM protein Source Concentration used Provider 
Bovine collagen G 
(consists mainly of collagen I) 
Bovine calf skin 300 µg/ml Biochrom AG 
Human collagen, type IV Human placenta 300 µg/ml BD Biosciences 
Human fibronectin Human plasma 1 mg/ml Harbor Bio-Products 
Mouse laminin (laminin-1) Engelbreth-Holm- 
Swarm tumors 
300 µg/ml Harbor Bio-Products 
Human vitronectin Human plasma 100 µg/ml R&D Systems 
 
Table II.7: Expected size of uncleaved extracellular matrix proteins 
ECM protein Composition/Expected bands in SDS-Page 
Collagen type I α1 chain ~ 139 kDa, α2 chain ~ 129 kDa 
dimer ~ 290 kDa, trimer ~ 400 kDa 
Collagen type IV α1 chain ~ 185 kDa, α2 chain ~ 170 kDa 
additional band at 160 kDa 
Fibronectin 220 kDa monomer 
Laminin α chain ~ 400 kDa 
β chain ~ 230 kDa, γ chain ~ 220 kDa 
Vitronectin Monomeric glycoprotein detected as a mixture of 
65 kDa and 75 kDa polypeptides 
 
 
2.6.5 Immunoprecipitation 
Immunoprecipitation is a technique to isolate a particular protein out of a solution by using a 
specific antibody. The sample volume equivalent to 150 µg of protein was incubated for 
2 hours at 4°C with 5 µg antibody and 100 µl Protein G Beads (µMACSTM Protein G 
MicroBeads, Miltenyi Biotec). The tubes were gently agitated. Thereby a protein-antibody-
beads-complex is formed. 
Immunoprecipitation was performed using a magnetic separation unit (µMACS Separator) 
and the corresponding columns (µ Columns) from Miltenyi Biotec. The samples were added 
to the columns. The magnetic beads and all bound molecules stick to the column, whereas the 
residual sample flows through. Subsequently, the columns were rinsed 4 times with 200 µl of 
lysis buffer. To detach the precipitates from the microbeads, 20 µl of sample buffer, which 
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was heated to 95°C, was added and collected after passing the column. Then a SDS-Page and 
a western blot were performed corresponding to chapter II.2.6.3. 
To ensure equal protein loading, a part of each cell lysate used for immunoprecipitation 
experiments was separately analyzed in western blots using the particular detection antibody. 
Table II.8: Precipitation antibodies for immunoprecipitation 
Antigen Isotype Provider and product number 
FGF-2 Mouse monoclonal IgG1κ Upstate, 05-118 
Integrin αvβ3 Mouse monoclonal IgG1 Chemicon, MAB1976 
 
 
2.6.6 Enzyme-linked immunosorbent assay 
Similar to a western blot, an enzyme-linked immunosorbent assay (ELISA) is an 
immunological technique to specifically detect antigens. It is performed in 96 well plates 
using specific antibodies and an enzymatic reaction for detection. 
To determine the protein-protein interaction of Hsp27 and FGF-2, a double sandwich ELISA 
mixing two commercially available ELISA kits one for Hsp27 (PathScan phospho-Hsp27 
(Ser78) Sandwich ELISA Kit, Cell Signaling), the other for the detection of FGF-2 
(Quantikine bFGF ELISA, R&D Systems), was developed. Firstly, 100 µl of each cell lysate 
and 100 µl of the sample diluent (PathScan) were mixed and vortexed. Then 100 µl of this 
solution were added to a multiwell plate (PathScan), which was pre-coated with a Hsp27 
antibody by the manufacturer, and incubated for 2 hours at 37°C. The fluid in the plate was 
then discarded and the wells were washed 4 times with 200 µl of wash buffer (PathScan). 
Subsequently, 200 µl of a FGF-2 antibody conjugated with horse radish peroxidase 
(Quantikine) were added and incubated for 2 hours at room temperature. The washing 
procedure was then repeated using the Quantikine wash buffer. Next, 200 µl of the substrate 
solution, an equal mixture of solution A (hydrogen peroxide) and B (3,3’,5,5’-
tetramethylbenzidine), were added and the plate was incubated for 30 minutes in the dark. At 
last 50 µl of the stop solution (1 M sulfuric acid) were added. The absorbance was measured 
at 450 nm (reference wavelength 550 nm). 
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Figure II.9: Illustration of the self-made Hsp27-FGF-2 ELISA 
Self-made Hsp27-FGF-2 ELISA: Firstly, Hsp27 was bound to the microwell plate coated with an 
Hsp27 antibody. Secondly, FGF-2 was detected by using an FGF-2 antibody conjugated with horse 
radish peroxidase (HRP). 
2.7 MICROSCOPY 
2.7.1 Fluorescence microscopy 
Fluorescence microscopy is an effective method for the subcellular localization of 
fluorescently labeled proteins. Fluorescence is the property of molecules or chemical groups, 
called fluorophores, to absorb high-energy short-wavelength light and emit low-energy long-
wavelength light. Antibodies labeled with fluorescent dyes, e.g. from the Alexa Fluor family, 
are used in fluorescence microscopy. These molecules differ in their excitation and emission 
wavelength and therefore allow multicolor detection. A fluorescence microscope usually 
consists of a light source, in most cases a high pressure mercury lamp, an excitation filter, a 
dichroic beam-splitter, an emission filter, a detector and a camera. An optimal separation of 
the excitation light and the fluorescence emission emanating from the sample is a basic 
requirement of the microscopes optical system. The inverted microscope Axiovert 200M or 
the upright microscope Axiophot (Carl Zeiss) was used to perform fluorescence microscopy. 
2.7.2 Confocal laser scanning microscopy 
A confocal laser scanning microscope is equipped with a confocal pinhole that eliminates out-
of-focus light. Thus a much higher resolution can be obtained. The laser beam is focused to a 
point and scanned across the sample. A photomultiplier tube (PMT) detects the emitted 
fluorescence. In this study a Leica TCS SP5 (Leica Microsystems) microscope equipped with 
an argon (488 nm) and two helium-neon lasers (543 nm, 633 nm) was used. 
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Figure II.10: Confocal scanning laser microscope 
The light pathway of a confocal scanning laser microscope: Line-by-line scanning by a focused laser 
beam and pixel-by-pixel detection using a photomultiplier tube (PMT). 
2.7.3 Fluorescence staining 
Unless stated otherwise, glass coverslips (Ø 13 mm) were coated with collagen G (10 µg/ml), 
while incubating them for 30 minutes at 4°C followed by 30 minutes at 37°C. Some 
additional experiments were performed using fibronectin coating (10 µg/ml). PAEC were 
seeded onto these coverslips that were placed in 24 well plates. After 24 hours and at 100% 
confluency, cells were stimulated with shear stress or porcine pancreatic elastase as described 
in chapter II.2.1.1.2 and II.2.1.2. Subsequently, cells were washed with PBS+ and fixed with 
3.7% formaldehyde in PBS+ for 10 minutes followed by another wash step. Cell 
permeabilization with 0.3% Triton X-100 in PBS+ was performed for 3 minutes. Then cells 
were washed 3 times and 1% BSA in PBS+ was added to block unspecific protein binding 
sites. After an incubation period of 30 minutes, the primary antibody solution was added and 
left there overnight at 4°C. The next day, the fixed cells were washed at least 3 times. 
Following, the secondary antibody was added and incubated for 30 minutes in the dark. 
Finally, the coverslips were removed with tweezers and were transferred upside-down on a 
drop of Mounting Medium (Shandon Immu-Mount, Thermo Scientific) onto an object holder. 
Coverslips were sealed with transparent nail polish. Microscopy was performed by using 
either the confocal laser scanning microscope Leica TCS SP5 (Leica Microsystems, 
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objectives: 40x NA 1.25; 63er NA 1.4 oil) or one of two fluorescence microscopes (Axiovert 
200M (Carl Zeiss), objective: 63x NA 1.2 oil or Axiophot (Carl Zeiss), objective: 100x NA 
1.3 oil). The appropriate objective, resolution and distance between two optical slices (z-step 
size) are indicated in the figure legend. 
Table II.9: Primary antibodies for immunofluorescence 
Antigen Isotype Dilution Provider and  
product number 
Collagen type IV Rabbit polyclonal IgG 1:400 in 1% BSA Abcam 
ab19808 
FAK Rabbit polyclonal IgG 1:100 in 1% BSA Santa Cruz 
sc-558 
Fibronectin Rabbit polyclonal 
Ig fraction of antiserum 
1:200 in 1% BSA Dako 
A0245 
ILK Mouse monoclonal 
IgG2b 
1:100 in 1% BSA Santa Cruz 
sc-20019 
Laminin Rabbit polyclonal 1:50 in 1% BSA Sigma-Aldrich Inc. 
L9393 
LAMP1 Rabbit polyclonal 1:100 in 1% BSA Sigma-Aldrich Inc. 
L1418 
Neutrophil elastase Mouse monoclonal IgM 1:50 in 1% BSA Santa Cruz 
sc-59335 
Vitronectin Rabbit polyclonal IgG 1:50 in 1% BSA Santa Cruz 
sc-15332 
vWF Rabbit, IgG fraction of 
antiserum 
1:100 in 1% BSA Sigma-Aldrich Inc. 
F3520 
 
Table II.10: Other fluorescent molecules 
Fluorescent dye Dilution Provider 
Alexa Fluor 488 phalloidin 1:40 in PBS+, 1% BSA Molecular Probes Inc. 
DAPI 1:2,000 in PBS+, 1% BSA Invitrogen 
 
Table II.11: Secondary antibodies for immunofluorescence 
Antibody Dilution Provider 
Alexa Fluor 488 chicken-anti-mouse IgG 1:200 in PBS+, 1% BSA Invitrogen 
Alexa Fluor 546 goat-anti-rabbit IgG 1:200 in PBS+, 1% BSA Invitrogen 
 
 
2.7.4 Electron microscopy 
PAEC were dissolved using accutase and fixed in a mixture of 0.1% glutaraldehyde and 4% 
formaldehyde, which was freshly prepared from paraformaldehyde (in Sorensen’s buffer). All 
further steps were performed by our collaboration partners at the Institute of Anatomy 
(Ludwig-Maximilians-Universität, Munich). Cells were embedded in Lowicryl (Polysciences 
48  MATERIALS AND METHODS 
 
Inc.). Using an ultramicrotome (Ultracut E Microtome, Reichert-Jung), ultrathin sections of 
90 nm were cut and collected in nickel grids. The grids were left to dry overnight. The next 
day, sections were washed with water, rinsed with PBS- and incubated with glycine (50 mM) 
for 20 minutes. The grids were then washed 3 times for 5 minutes each with PBS- and 
incubated in blocking solution for 30 minutes at room temperature (Blocking solution for 
goat-gold conjugates, Aurion). After shortly rinsing the section with PBS- containing 1% 
BSA-c (acetylated bovine serum albumin from Aurion), they were either incubated with a 
mixture of the anti-elastase and anti-vWF antibody or with buffer at room temperature 
overnight. Then, the grids were washed with PBS- BSA-c, incubated with secondary 
antibodies and washed again with PBS-. 2% glutaraldehyde was added for 10 minutes. After 
rinsing the grids in a drop PBS- and subsequently washing them 3 times with water, they were 
stained with uranyl acetate for 20 minutes and rinsed with water. The grids were examined in 
a Philips CM-10 Transmission Electron Microscope (Philips). 
Sorensen’s buffer (ph 7.4) 
KH2PO4 (15 M/l) 18.2 ml 
Na2HPO4 (30 M/l) 81.8 ml 
 
Table II.12: Primary antibodies for electron microscopy 
Antigen Isotype Dilution Provider and 
product number 
Neutrophil elastase Mouse monoclonal IgM 1:100 Santa Cruz 
sc-59335 
vWF Rabbit, IgG fraction of 
antiserum 
1:200 Sigma-Aldrich Inc. 
F3520 
 
Table II.13: Seconary antibodies for electron microscopy 
Antibody Dilution Provider 
Gold-labeled (6 nm)-goat-anti-mouse 1:40 Aurion 
Gold-labeled (10 nm)-goat-anti-rabbit 1:40 Aurion 
 
 
2.8 FLOW CYTOMETRY 
Flow cytometry is a widely used method for the quantitative analysis of cell properties, which 
are relative cell size, granularity and fluorescence intensity. This technology can be used for a 
range of applications such as cell counting, cell cycle analysis, determination of cell viability 
and apoptosis or analysis of protein expression and localization. A flow cytometer consists of 
the following components: a fluidics system, an optical system, an electronic system and a 
computer. A cell sorter (FACS – fluorescence activated cell sorting) additionally separates the 
cells, based on their specific scattering and fluorescent characteristics. 
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In flow cytometry, the cells are injected into the center of a sheath flow, hydrodynamically 
focused and single cells are delivered to the laser beam. Forward and side scatter as well as 
fluorescence intensities at several wavelengths of each cell can be rapidly, simultaneously 
measured. The low angle forward scatter intensity is approximately proportional to the cell 
diameter while the orthogonal (90°) scatter intensity is roughly proportional to the degree of 
complexity and the amount of granular structures within the cell. 
Sheath fluid
Cell suspension
Laser ray
Forward scattered
light
Side scattered
light
 
Figure II.11: Flow cytometry – hydrodynamic focusing and light scatter 
 
 
Different cell types vary in their surface molecules, which are classified in the clusters of 
differentiation (CD) nomenclature. The analysis of expression patterns of CD molecules is the 
basis of cell immunophenotyping by flow cytometry. For this, fluorochrome-labeled 
antibodies are used. Common fluorescent dyes include fluorescein isothiocyanate (FITC), 
AlexaFluor 488, green fluorescent protein (GFP) or phycoerythrin (PE). 
The phenotyping of PAEC and HUVEC was performed using the BD FACSort from Becton 
Dickinson equipped with one 488 nm laser which is able to measure three colors 
simultaneously. The cytometer was connected to a computer, where data was analyzed with 
the CellQuest software (Becton Dickinson). Sheath fluid (BD FACSFlowTM), cleaning (BD 
FACSClean Solution) and rinsing solution (BD FACSRinse Solution) were also provided by 
Becton Dickinson. 
2.8.1 CD31 expression 
Platelet endothelial cell adhesion molecule (PECAM-1/CD31), an endothelial cell surface 
marker protein, was used to determine the purity of the primary endothelial cell cultures. For 
this purpose, confluent cells were rinsed with PBS- and 1 ml of accutase was added per 10 cm 
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dish to induce cell detachment and separation in single cells. The enzymatic reaction was 
stopped by adding 3 ml of FCS-containing medium. The cell solution was centrifuged and the 
supernatant discarded. Afterwards, the cell pellet was dissolved in 1 ml PBS+ containing 10% 
FCS and 1% sodium azide. Cells were counted and each tube was filled with 1 million cells. 
The samples were centrifuged and the supernatants were discarded. One tube was incubated 
with the CD31-PE-labeled antibody, another with the isotype control antibody (mouse IgG1 
PE, Becton Dickinson). After an incubation period of 1 hour at 4°C, cells were centrifuged 
and washed 3 times with PBS+, 10% FCS, 1% NaN3. Subsequently, the cells were analyzed 
by flow cytometry. 
4: CD31 antibodies for flow cytometry 
Antigen Isotype Dilution 
ber 
Table II.1
Provider and  
product num
Porcine CD31 PE Mouse mon c
IgG1 
o lonal 
, 3% BSA 
1:200 
PBS+
AbD Serotec 
MCA1746PE 
Human CD31 PE Mouse IgG1κ 1:33 
PBS+, 3% BSA 
mingen 
555446 
BD Phar
 
 
2.8.2 Release of vWF 
stantly present 
during antibody incubations and washes, with exception to the last wash step. 
5: vWF antibod  cytometry 
Antigen Isotype Dilution 
ct number 
To examine whether shear stress induces the release of vWF indicating the exocytosis of 
Weibel-Palade bodies, the amount of vWF inside the cells was analyzed by flow cytometry. 
Less intracellular vWF staining would be an indication for the release of this protein. After 
shear stress treatment (see chapter II.2.1.1), cells were detached as described in chapter 
II.2.8.1. They were fixed with 0.5% formaldehyde for 15 minutes, permeabilized with 0.5% 
saponin for 20 minutes and washed with PBS containing 10% FCS and 1% sodium azide. 
Then the vWF antibody or the isotype control (mouse IgG1, BD Pharmingen) was added and 
incubated at 4°C for 60 minutes. Again, the cells were washed and incubated with the 
secondary antibody (anti-mouse PE, BD Pharmingen) for 30 minutes. After repeating the 
washing procedure for 3 times, the samples were measured. Saponin was con
Table II.1 y for flow
Provider and  
produ
Human vWF  monoclonal 
IgG1κ 
1:20 in PBS+, 3% BSA 
M0616 
Mouse Dako 
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2.9 POLYMERASE CHAIN REACTION 
The invention of the polymerase chain reaction (PCR) was a revolution in molecular biology. 
PCR is a technique that allows the amplification of specific regions of a DNA strand. In 1993, 
Kary B. Mullis received the Nobel Prize in Chemistry for investigating the PCR 132. 
Every PCR involves three major steps. The sequence of these steps is called cycle and is 
repeated around 20 to 40 times. Every cycle consists of the DNA denaturation, the primer 
hybridization and the synthesis of new double-strands by a DNA polymerase. Denaturation of 
DNA at temperatures of 94°C melts the DNA to single strands. Afterwards a temperature of 
around 50 to 65°C is used to allow primers to bind at their complementary sequence, the so 
called annealing. Primers are short oligonucleotides that serve as starting point for DNA 
replication. In the final elongation step the polymerase synthesizes the complementary strand 
by adding dNTPs (deoxynucleoside triphosphates), using the existing single strand as 
template. 
dsDNA
Denaturation 94°C
3‘                                                              5‘
5‘                                                              3‘
3‘                                                              5‘
5‘                                                              3‘
Primer 1 Primer 2 Annealing 50 - 65°C
3‘                                                              5‘
5‘                                                              3‘
Elongation 68°C / 72°C
3‘
3‘
 
Figure II.12: Polymerase chain reaction 
 
DNA-dependent DNA polymerases can only act on DNA templates. To investigate gene 
transcription, this means RNA analysis, the enzyme reverse transcriptase, which transcribes 
single-stranded RNA into complementary DNA (cDNA), is used. This reverse transcription 
followed by a PCR is called reverse transcription-PCR (RT-PCR). 
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2.9.1 Isolation of mRNA 
RNA isolation is the first step when performing RT-PCR. For this, the RNeasy Mini Kit from 
Qiagen was used. For cell lysis, a denaturizing guanidine thiocyanate buffer containing 
ß-Mercaptoethanol, which additionally inactivates RNases, was used. Afterwards, the cell 
lysate was chopped using QIAShredder columns, which were provided by Qiagen as well. By 
adding ethanol, the RNA was precipitated and bound onto silica-based membrane columns. 
After several different washing steps, the RNA was eluted using RNase free water. 
2.9.2 RT-PCR 
For RT-PCR the Titan One Tube RT-PCR Kit from Roche was used. Primers were designed 
with the Primer 3 software 167 and obtained from Eurofins MWG GmbH with the exception of 
the primers for ELANE Homo sapiens, which were obtained from Biomers.net. The 
manufacturer’s instructions were followed. The respective protocol including the single steps 
and the temperature profile is listed in Table II.17. Thermocycling was performed using a 
Mastercycler ep gradient S from Eppendorf. Additionally, all samples were analyzed for 
β-actin as internal control. RT-PCR products were separated and detected via agarose gel 
electrophoresis.  
Table II.16: Primers used for RT-PCR (HSA: Homo sapiens, SSC: Sus scrofa, AT: Annealing temp.) 
Primer Sequence AT [°C] Product 
length [bp] 
ELANE [HSA] Forward 
Reverse 
CGTAAACTTGCTCAAACGACATC 
CCCTCACGAGAGTGCAGACGTT 
56 241 
ELA1 [HSA] Forward 
Reverse 
GCTATGTCCAGCTGGGTGTT 
AGCAGAGACCTGGGTGAAGA 
55 364 
ELA2A/B [HSA] Forward 
Reverse 
CCCTGCAGTACAGCTCCAAT 
CTGGAGCAGGTGGCATAGTC 
56 429 
ELA3A/B [HSA] Forward 
Reverse 
GACCTACCAGGTGGTGTTGG 
GGCTTGCTATGGTCTCCTCA 
56 571 
ELANE [SSC] Forward 
Reverse 
CAGCCTCTCCACCAATGAAC 
CATTGCAGCTGGAAATGATG 
53 376 
ELS1 [SSC] Forward 
Reverse 
AACCTGAACCAGAACGATGG 
ATCACCCTGACATCCAGAGC 
53 380 
β-actin Forward 
Reverse 
CCAAGGCCAACCGCGAGAAGATGAC 
AGGGTACATGGTGGTGCCGCCAGAC 
53-56 586 
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Table II.17: RT-PCR protocol 
Step Time Temperature Cycles 
Reverse transcription 30 min 50°C  
Denature template 2 min 94°C  
Denaturation 
Annealing 
Elongation 
30 s 
30 s 
45 s 
94°C 
see Table II.16 
68°C 
 
10 x 
Denaturation 
Annealing 
Elongation 
30 s 
30 s 
45 s (+ 5 s per cycle) 
94°C 
see Table II.16 
68°C 
 
25 x 
Prolonged elongation 7 min 68°C  
 
 
2.9.3 Real time RT-PCR 
Real time RT-PCR allows the quantitative determination of RNA expression. It was 
performed using a Light Cycler 1.5 (Roche) and the QuantiTect SYBR Green RT-PCR Kit 
(Qiagen) according to the manufacturer’s instructions. SYBR Green I binds double-stranded 
DNA molecules. The fluorescence of the emerging complex was quantified at the end of 
elongation time. Cycling conditions as mentioned in Table II.19 were used. The results were 
normalized to 18S rRNA as endogenous reference gene. 
Table II.18: Primers used for real time RT-PCR (SSC: Sus scrofa) 
Primer Sequence Product length [bp] 
FGF-2 [SSC] Forward 
Reverse 
TCAAAGGAGTGTGTGCGAAC 
CAGGGCCACATACCAACTG 
161 
18S rRNA Forward 
Reverse 
TCAAGAACGAAAGTCGGAGG 
GGACATCTAAGGGCATCACA 
488 
 
Table II.19: Real time RT-PCR protocol 
Step Time Temperature 
Reverse transcription 20 min 50°C 
PCR initial activation step 15 min 95°C 
Cycling 
Denaturation 
Annealing 
Elongation 
Data acquisition 
 
15 s 
30 or 50 s 
30 s 
5 s 
 
94°C 
60°C 
72°C 
77°C (FGF-2), 81°C (18S rRNA) 
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2.9.4 Agarose gel electrophoresis 
A mixture of 1% agarose in TBE buffer was boiled in a microwave oven until the agarose was 
dissolved. The solution was left to cool down to approximately 40 to 50°C. After the addition 
of ethidium bromide (0.05 µg/ml), the solution was transferred to the electrophoresis unit 
(Peqlab Biotechnologie GmbH). After gel polymerization, TBE electrophoresis buffer 
containing additional ethidium bromide was added. The DNA marker (2Log DNA Ladder, 
New England Biolabs) and the samples containing sample buffer in a 1:6 ratio were loaded 
onto the gel. Electrophoresis was performed at 100 mA using a Phero-Stab 0310 power 
supply from Biotec-Fischer. The fluorescence of the PCR products intercalated with ethidium 
bromide was documented with a Gel Doc 1000 station from Bio-Rad. 
TBE buffer (pH 8.3)   
Tris 89 mM 
Boric acid 89 mM 
EDTA 2.5 mM 
 
Sample buffer 6x   
Tris (pH 7.6) 10 mM 
Bromophenol blue 0.03 % 
Xylene cyanol 0.03 % 
Glycerol 60 % 
EDTA 60 mM 
 
 
3 STATISTICS 
Every experiment was performed at least three times. Data are expressed as mean values ± 
SEM. Statistical tests were performed using SigmaStat version 2.03 statistic software (SPSS 
Inc.). To compare two samples, the paired t-test was used. For the comparison of more than 
two samples, one-way analysis of variance for repeated measures (ANOVA RM) followed by 
the Student-Newman-Keuls test was applied. In cases where data were not normally 
distributed the ANOVA on ranks was used for statistical testing. The test that was used is 
indicated in the respective figure legend. P-values less than 0.05 were considered significant. 
 RESULTS 
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III RESULTS 
1 CELL CHARACTERIZATION 
1.1 CD31 STAINING OF PAEC AND HUVEC 
CD31 (PECAM-1) cell surface staining of PAEC and HUVEC was performed to monitor the 
purity of the endothelial cell populations. For this purpose, cells of passage II were analyzed 
by flow cytometry. In PAEC cultures 96% of the cells were positive for CD31 (mean 
fluorescence intensity: isotype 25.6 vs. CD31 229.3), indicating that less than 4% of these 
cells were negative for CD31, as smooth muscle cells are. In HUVEC cultures 97% of the 
cells were CD31-positive (mean fluorescence intensity: isotype: 14.9 vs. CD31 280.2) 
(Figure III.1). 
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Figure III.1: Endothelial cell culture purity tested via flow cytometry 
PAEC (A) and HUVEC (B) were stained for CD31 and analyzed in a flow cytometer. The left panel 
shows a representative dot plot (FCS-H vs. SSC-H) of the cell populations (10,000 cells). The right 
panel displays the fluorescence histogram of 50,000 cells. The filled grey curves represent the isotype 
control whereas the empty curves are the CD31 stained cell population. For PAEC two and for 
HUVEC three independent cell populations were analyzed. One representative histogram is shown. 
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2 ELASTASE AS PART OF THE MECHANOTRANSDUCTION CASCADE 
2.1 SHEAR STRESS-INDUCED FGF-2 RELEASE IS ELASTASE DEPENDENT 
Porcine aortic endothelial cells were kept under static conditions or exposed to a shear stress 
of 16 dyn per cm² for about 120 minutes using the cone and plate apparatus. Supernatants 
were collected and the concentration of FGF-2 in these samples was measured. While the 
FGF-2 concentration in supernatants of static control cells amounted to 106.5 ± 23.7 pg/ml, 
its concentration in supernatants of sheared cells was more than 3 times higher 
(344.2 ± 65.1 pg/ml, p < 0.001). To check whether elastase influences this shear stress-
induced FGF-2 release, elastase activity was blocked using an unspecific and a specific 
inhibitor for elastase. Inhibition of elastase with the non-specific serine protease inhibitor 
chymostatin as well as with the specific inhibitor MeOSuc-Ala-Ala-Pro-Val-
chloromethylketone significantly reduced the shear stress-induced increase in FGF-2 
(167.6 ± 73.3 pg/ml and 153.0 ± 73.4 pg/ml respectively). Abciximab, an integrin αvβ3 
blocker, abolished FGF-2 secretion into the supernatant (124.9 ± 18.7 pg/ml) (Figure III.2), 
which was already demonstrated by Gloe et al. 75. 
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Figure III.2: Shear stress-induced FGF-2 release depends on elastase and integrin αvβ3 
Quantification of FGF-2 in cell supernatants after the application of shear stress (16 dyn/cm², 
120 minutes) is shown in comparison to static controls. Elastase inhibition was performed using 
chymostatin (CHY, 10 µg/ml) or MeOSuc-Ala-Ala-Pro-Val-chloromethylketone (MEO, 50 µM). The 
integrin αvβ3 was blocked with abciximab (ABC, 1 µg/ml) (n = 7, mean + SEM; * p < 0.001 vs. static, 
# p < 0.001 vs. shear, ANOVA RM, Student-Newman-Keuls). 
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2.2 ELASTASE IS RELEASED UPON SHEAR STRESS STIMULATION 
To check whether elastase is released by shear stress exposure, the supernatants were 
analyzed. After 120 minutes of shear stress exposure, a significantly higher elastase activity 
was detected in the extracellular compartment compared to static control cells (static 0.0619 ± 
0.0103 U/ml, shear 0.2036 ± 0.0288 U/ml). The activity was measured using the specific 
substrate MeOSuc-Ala-Ala-Pro-Val-p-nitroaniline. In order to investigate whether integrin 
αvβ3 activation was needed for elastase release, the integrin was blocked using abciximab. 
Integrin αvβ3 inhibition did not affect the shear stress-induced release of elastase (shear + 
ABC 0.1454 ± 0.0120 U/ml) (Figure III.3A). 
In order to confirm elastase release upon shear stress, western blot analysis was performed 
using an antibody that detects human neutrophil elastase. In supernatants of PAEC and 
HUVEC exposed to shear stress the enzyme was detected whereas control supernatants 
showed no band in western blot (Figure III.3B).  
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Figure III.3: Shear stress induces the release of an enzyme with elastase activity 
(A) Elastase activity in supernatants of cells under static conditions and cells exposed to shear stress 
for 120 minutes was measured using the specific substrate MeOSuc-Ala-Ala-Pro-Val-p-nitroaniline 
(MeOSuc-Ala-Ala-Pro-Val-pNA) (1 µg/ml). Integrin αvβ3 was inhibited with abciximab (ABC, 1 µg/ml) 
(n = 20, mean + SEM, * p < 0.05 vs. static, n.s. = not significant, ANOVA RM on Ranks, Student-
Newman-Keuls). (B) The concentrated supernatants of untreated cells and cells exposed to 120 
minutes of shear stress were analyzed by western blot using an anti-neutrophil elastase antibody 
(antibody No. 2). 
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3 CHARACTERIZATION OF ENDOTHELIAL ELASTASE 
3.1 ENDOTHELIAL ELASTASE DIFFERS FROM PANCREATIC AND 
NEUTROPHIL ELASTASE 
In order to figure out whether the released elastase was indeed neutrophil or pancreatic 
elastase, RT-PCR experiments of cell lysates of PAEC and HUVEC were performed. As 
leukocytes are known to contain neutrophil elastase, human and porcine mononuclear cells 
were isolated with Ficoll gradient centrifugation and used as positive control for this elastase. 
Extracts from human and porcine pancreas were used as positive control for the pancreatic 
elastases. RT-PCR experiments revealed that neither neutrophil nor pancreatic elastase are 
expressed in PAEC as well as in HUVEC on mRNA level (Figure III.4).  
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Figure III.4: No endothelial mRNA expression of neutrophil and pancreatic elastase 
RT-PCR of PAEC and HUVEC was performed to detect mRNA expression of (A) human neutrophil 
elastase [ELANE], (B)/(C) human pancreatic elastases (ELA1, ELA2, ELA3) and (D) porcine elastases 
(ELS1, ELANE (the porcine ELANE mRNA was not detectable in porcine mononuclear cells but in 
porcine pancreas)). As controls human and porcine mononuclear cells (hMNZ, pMNZ) and pancreatic 
extracts from human and pig were used. β-actin served as internal control for each sample. HSA = 
Homo sapiens, SSC = Sus scrofa. 
To investigate elastase expression on protein level, western blot analysis using antibodies 
against human neutrophil elastase (antibody No. 1) and pancreatic elastase was performed. As 
expected, and in correlation with RT-PCR data, neither neutrophil nor pancreatic elastase was 
detected in western blots of PAEC and HUVEC. Surprisingly, another antibody against 
neutrophil elastase (antibody No. 2) that was used for the detection of elastase in cell 
supernatants (see Figure III.3) was effective in detecting the enzyme in both endothelial cell 
types, maybe due to cross-reactions. 
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These results suggest that neither neutrophil nor pancreatic elastase are expressed in 
endothelial cells, but that another not yet described elastolytic enzyme, showing homology to 
neutrophil elastase, is present in endothelial cells and released upon shear stress exposure 
(Figure III.3). For the rest of this manuscript this enzyme will be termed endothelial elastase. 
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Figure III.5: Endothelial elastase detectable with an antibody against neutrophil elastase 
(A) Endothelial elastase was analyzed by using two neutrophil elastase (NE) antibodies, probably 
raised against different epitopes of the enzyme. The upper panel shows a western blot with antibody 
No. 1, which does not recognize endothelial elastase, which antibody No. 2 does (lower panel). (B) An 
antibody against porcine pancreatic elastase (PPE) failed to detect endothelial elastase. GAPDH was 
used to control protein loading. HMNZ, pMNZ = Human and porcine mononuclear cells. 
4 INTRACELLULAR STORAGE OF ENDOTHELIAL ELASTASE 
4.1 ENDOTHELIAL ELASTASE COLOCALIZES WITH VWF 
Since it was shown that an elastase mediates the shear stress-induced FGF-2 release, the 
release and intracellular storage of this enzyme was further examined using the neutrophil 
elastase antibody mentioned in chapter III.3.1.  
Weibel-Palade bodies are prominent secretory vesicles in endothelial cells. These bodies 
contain among other substances von Willebrand Factor (vWF), a protein involved in platelet 
adhesion and coagulation. Since Galbusera et al. demonstrated that vWF is released from 
Weibel-Palade bodies upon shear stress, these endothelial vesicles were investigated here 67. 
In immunofluorescence experiments (Figure III.6), endothelial elastase was found to 
colocalize with vWF in the cytosol, indicating endothelial elastase to be also stored in 
Weibel-Palade bodies. In contrast, cytosolic colocalization with LAMP1 (lysosomal-
associated membrane protein-1), a lysosomal protein, was not detected.  
To confirm the finding that elastase and vWF colocalize in Weibel-Palade bodies, electron 
microscopy using double immunogold labeling was performed. The negative control did not 
show any unspecific binding of immunogold particles. In positive samples a colocalization of 
elastase and vWF at cell border areas and inside the cytoplasm was detected (Figure III.7). 
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Figure III.6: Colocalization of endothelial elastase and vWF 
The intracellular distribution of (A) elastase (anti-NE, antibody No. 2) and vWF (63x objective, pixel 
size: 0.08 x 0.08 µm, z-step size: 0.25 µm, projection) or (B) elastase (anti-NE, antibody No. 2) and 
LAMP-1 (40x objective, pixel size: 0.06 x 0.06 µm, z-step size: 0.5 µm, projection) was analyzed with 
confocal laser scanning microscopy. 
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Figure III.7: Electron microscopy of endothelial elastase and vWF 
Double-labeling immunogold electron microscopy of elastase (small 6-nm immunogold particles) (anti-
NE, antibody No. 2) and vWF (large 10-nm immunogold particles) was performed in untreated PAEC: 
(A) image of the cytosolic region, (B) image of the cell border area (the arrow indicates the cell border). 
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4.2 ENDOTHELIAL ELASTASE AND VWF ARE RELEASED UPON SHEAR 
STRESS STIMULATION 
To investigate whether both proteins – vWF and endothelial elastase – are released upon shear 
stress stimulation, flow cytometry and western blot analysis was performed. Flow cytometry 
experiments revealed that after 240 minutes of shear stress 30% less vWF was detectable 
inside the cells (mean cell fluorescence: static 37.0 ± 1.6 vs. shear 27.1 ± 2.4) indicating 
release of vWF upon shear stress. This finding was confirmed using western blot analysis. 
Whereas after 120 minutes of shear stress no change in the amount of intracellular stored 
vWF was noticed, after 240 minutes less vWF was detected in cell lysates of sheared cells 
compared to static cells. The same was true for endothelial elastase (Figure III.8).  
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Figure III.8: Shear stress induces the release of vWF – intracellular analysis 
(A) Flow cytometry of static PAEC and cells exposed to shear stress (16 dyn/cm², 240 minutes) (n = 5, 
mean + SEM, * p < 0.05 vs. static, paired t-test) showing intracellular vWF expression. The filled grey 
curve represents the isotype control whereas the empty curves are vWF stained cells (black line: static 
cells, grey line: cells exposed to shear stress). The isotype served as negative control. Appropriate 
mean fluorescence intensities are illustrated in the graph on the right. (B) Furthermore, static cells and 
cells exposed to shear stress (16 dyn/cm², 120 or 240 minutes) were analyzed for endothelial elastase 
(antibody No. 2 against neutrophil elastase) and vWF protein expression by western blot experiments. 
GAPDH was used as control for equal protein loading. A representative blot of three independent 
experiments is presented. 
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In order to prove release of vWF into the supernatant, western blot analysis was performed. 
Whereas the intracellular amount of vWF decreased (Figure III.8), the level of vWF increased 
in the extracellular compartment. After 120 and 240 minutes of stimulation with shear stress, 
vWF was detectable in cell supernatants, whereas no vWF band was detected in supernatants 
of static controls (Figure III.9A). To obtain quantitative data, an ELISA was performed. As 
this kit was not able to detect the porcine protein in PAEC supernatants, the assay was 
performed by using HUVEC. After 120 minutes of stimulation a 3 fold higher amount of 
vWF was detected in supernatants of cells exposed to shear stress than in untreated controls 
(static 2.0 mU/mg ± 0.7 vs. shear 6.1 mU/mg ± 1.9). After 240 minutes of treatment with 
shear stress, the concentration of vWF in the supernatant was even higher (static 3.4 ± 1.0 
mU/mg vs. shear 9.1 ± 3.0 mU/mg) (Figure III.9B). As shown in chapter III.2.2, this increase 
coincided with an increase of elastase concentration in the supernatant. 
vW
F 
in
 th
e 
su
pe
rn
at
an
t/p
ro
te
in
 [m
U
/m
g]
0
2
4
6
8
10
12
14
Static
Shear
120 240 Time [min]
Static Shear Static Shear
120 240
vWF
Time [min]
A
B
*
*
vW
F 
in
 th
e 
su
pe
rn
at
an
t/p
ro
te
in
 [m
U
/m
g]
 
Figure III.9: Shear stress induces the release of vWF – extracellular analysis 
PAEC or HUVEC were either kept as static controls or subjected to a shear stress of 16 dyn/cm² for 
120 or 240 minutes. (A) PAEC supernatants were analyzed with western blots. One representative 
experiment out of three is shown. (B) Quantification of vWF in HUVEC supernatants was performed 
using an ELISA (n = 5, mean + SEM, * p < 0.05 vs. static, paired t-test). 
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5 EFFECTS OF EXOGENOUSLY APPLIED ELASTASE ON ENDOTHELIAL 
CELLS 
5.1 ELASTASE TREATMENT INDUCES FGF-2 RELEASE 
Since it was shown that shear stress induces the release of FGF-2, we investigated whether 
this release was also possible by exogenous application of elastase without shear stress. 
Therefore, cells were stimulated with porcine pancreatic elastase for 5, 10, 30 or 60 minutes. 
The concentration of FGF-2 in the supernatant increased in a time-dependent manner, 
reaching a significant difference to untreated controls after 60 minutes of stimulation (control 
63.2 ± 12.0 pg/ml, elastase (60 min) 161.7 ± 21.4 pg/ml) (Figure III.10). 
To test whether treatment with exogenously applied elastase induced the de novo synthesis of 
FGF-2, real time RT-PCR was performed. Neither after 8 nor after 16 hours FGF-2 mRNA 
expression was changed by elastase application (Figure III.11). 
In order to check whether the source of the increased FGF-2 in the supernatant is either 
extracellular FGF-2, which was cut off from the matrix or cell surface proteoglycans, or 
intracellular FGF-2, being released from the cytosol, cells were treated with heparinase I. 
Heparinase I is an enzyme that cleaves heparan sulfate and heparin 122, which are major 
binding sites of FGF-2 on the cell surface. Incubation with heparinase for 60 minutes did not 
increase the concentration of FGF-2 in the supernatant, which was virtually identical with the 
concentration of FGF-2 in supernatants of untreated control cells (static 35.8 ± 5.3 pg/ml vs. 
heparinase 39.5 ± 5.8 pg/ml) (Figure III.12). Simultaneous application of elastase and 
heparinase did not further increase the FGF-2 concentration in the supernatant as compared to 
cells treated with elastase alone (elastase 124.3 ± 10.6 pg/ml vs. elastase + heparinase 128.7 ± 
16.2 pg/ml). 
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Figure III.10: Elastase induces the release of FGF-2 from endothelial cells 
PAEC were stimulated for 5, 10, 30 and 60 minutes with porcine pancreatic elastase (0.5 U/ml). 
Supernatants were collected and analyzed quantitatively for FGF-2 concentration using an ELISA 
(n = 6, mean + SEM, * p < 0.05 vs. control, ANOVA RM, Student-Newman-Keuls). 
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Figure III.11: Elastase has no influence on FGF-2 mRNA expression 
PAEC were left untreated or incubated with porcine pancreatic elastase for about 8 or 16 hours. 
Expression of FGF-2 mRNA was measured by real-time RT-PCR. 18S rRNA was used as 
endogenous reference gene (n = 4, each in duplicate, mean + SEM, paired t-test). 
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Figure III.12: Heparinase does not induce the release of FGF-2 from endothelial cells 
PAEC were left untreated or stimulated with porcine pancreatic elastase (0.5 U/ml) (ELA), 
heparinase I (0.5 U/ml) (HEP) or both (ELA + HEP) for 60 minutes. Supernatants were collected and 
analyzed for FGF-2 concentration using a commercially available ELISA Kit (n = 12 and n = 6 for ELA 
+ HEP, respectively, mean + SEM, * p < 0.05 vs. control, # p < 0.05 vs. ELA, ANOVA RM, Student-
Newman-Keuls). 
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5.2 ELASTASE INDUCES INTEGRIN-DEPENDENT OUTSIDE-IN SIGNALING 
5.2.1 Effects of elastase on extracellular matrix proteins 
Extracellular matrix proteins act as ligands for integrins. In order to study the effect of 
elastase on ECM proteins, different matrix proteins were incubated with porcine pancreatic 
elastase for 60 minutes. To separate those proteins, a SDS-Page, which was run under 
reducing conditions, followed by coomassie staining was performed. Porcine pancreatic 
elastase did not show any influence on collagen type I and IV, whereas laminin, fibronectin 
and vitronectin were cleaved into fragments of smaller molecular weight (Figure III.13). 
Molecular masses of denatured but yet uncleaved matrix proteins are summarized in Table 
II.7. Laminin degradation produced new bands at 100 and 60 kDa. Proteolytic degradation of 
fibronectin resulted in fragments of approximately 160, 120, 70, 65, 60 and 45 kDa. 
Vitronectin degradation produced a fragment of 35 kDa and fragments in the dye front (< 20 
kDa). The 27 kDa band represents pancreatic elastase, which was also loaded onto the gel in 
elastase treated samples. 
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Figure III.13: Specific degradation of matrix proteins by elastase 
SDS-Page and coomassie staining was performed to check the effect of elastase on different matrix 
proteins. Collagen type I (COL I, 300 µg/ml), collagen type IV (COL IV, 300 µg/ml), laminin (LM, 
300 µg/ml), fibronectin (FN, 1 mg/ml) and vitronectin (VN, 150 µg/ml) were incubated for 60 minutes 
with 0.5 U/ml porcine pancreatic elastase (+), or just solvent (-) (n = 3). The same degradation profile 
was observed when treating the matrix proteins with a 5-fold higher concentration of elastase (2.5 
U/ml). 
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To check the effect of elastase on endothelial cells and their extracellular matrix, PAEC 
grown on cell culture dishes for 24 hours were incubated with porcine pancreatic elastase. 
Cell supernatants, the cells and their extracellular matrix were separately isolated and 
analyzed for fibronectin, laminin and vitronectin by using western blots. Fibronectin, laminin 
and vitronectin were found to be degraded as compared to untreated controls (Figure III.14). 
However, the effect was less pronounced than observed after incubation of elastase with the 
isolated matrix components, the setup described above. Here, fibronectin fragments of 
approximately 160, 130, 120, 110 and 85 kDa and vitronectin fragments of 55, 43 and 35 kDa 
were detected. Whereas the protein fragments of laminin and vitronectin were found in the 
extracellular matrix layer, fibronectin fragments were detectable in the cell supernatant. By 
contrast, neither fragments of laminin nor vitronectin were found in supernatants (data not 
shown). 
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Figure III.14: Release of fibronectin fragments by elastase 
The effect of porcine pancreatic elastase (0.5 U/ml) on (A) fibronectin, (B) laminin and (C) vitronectin 
was tested using western blot analysis. The isolated extracellular matrix (ECM), the cell lysate 
including intracellular and cell-associated protein (CELLS) and the cell supernatant (SUP) of PAEC 
were analyzed. β-tubulin was used as control for equal protein loading. One representative image out 
of 3 is shown.  
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As shown in Figure III.15 with immunofluorescence experiments, PAEC originally plated in 
collagen type I, form a compact network of fibronectin fibrils upon cultivation for 24 h. To 
compare effects of elastase and shear stress on the structure of this network, PAEC were 
alternatively incubated with porcine pancreatic elastase or were directly exposed to shear 
stress for 120 minutes. Additionally experiments with shear stress supernatants, that contain 
endothelial elastase, were performed. All treatments induced similar alterations in the 
fibronectin matrix. After incubation with pancreatic elastase, extracellular fibronectin was 
almost not detectable anymore. In cells treated with shear stress supernatants or with shear 
stress a similar, but less pronounced, change of the network appeared. 
Compared to the pronounced changes in the fibronectin network, the structure of collagen 
type IV, laminin and vitronectin matrices were less affected by the application of pancreatic 
elastase (Figure III.16). The extra- and intracellular protein distribution of collagen type IV 
and vitronectin were not altered, while the laminin network appeared less dense than in 
untreated controls. 
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Figure III.15: Effects of elastase and shear stress on fibronectin macrostructure 
The intra- and extracellular distribution of fibronectin in PAEC was analyzed after exposure to different 
treatments using confocal microscopy: Upper panel represents controls: (A) without elastase, (B) 
treatment with control supernatant of static cells or (C) without shear stress. Lower panel: treatment 
with (D) porcine pancreatic elastase (0.5 U/ml, 60 minutes), (E) supernatant of sheared cells (shear 
stress of 16 dyn/cm² (120 minutes) was applied, supernatant was collected and given on static cells 
were for 60 minutes) or (F) shear stress (16 dyn/cm², 6 h, applied with the parallel plate apparatus) 
(40x objective, pixel size: 0.12 x 0.12 µm, z-step size A,B: 0.5 µm, C,D,E and F: 0.25 µm, projection). 
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Figure III.16: Effects of elastase on collagen type IV, laminin, vitronectin macrostructure 
Immunofluorescence images of collagen type IV, laminin and vitronectin in PAEC were taken using 
the confocal microscope. The upper panel shows the control cells, the lower panel the elastase 
treated cells (porcine pancreatic elastase, 0.5 U/ml, 60 minutes) (40x objective, pixel size: 0.12 x 0.12 
µm, z-step size: 0.5 µm, projection). 
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5.2.2 Effects of elastase on integrin αvβ3 
Activation of the integrin αvβ3 leads to its interaction with the adaptor protein Shc 36. To 
check the effect of shear stress on this interaction, coimmunoprecipitation experiments were 
performed. Shear stress induced a significantly higher association of two out of three Shc 
isoforms (46 and 52 kDa) and the integrin αvβ3 as compared to static controls (shear: 46 kDa: 
1.6 ± 0.3 and 52 kDa: 1.8 ± 0.3 fold over the static controls). The third Shc isoform of 66 kDa 
was not analyzed here as band density was too low in the western blots. Blocking of the 
elastase activity with the specific inhibitor MeOSuc-Ala-Ala-Pro-Val-chloromethylketone 
reduced the interaction of both Shc isoforms with the integrin (shear + MEO: 46 kDa: 1.3 ± 
0.3 and 52 kDa: 1.3 ± 0.2 fold over the static controls). For the 52 kDa isoform this reduction 
was significant (p < 0.05), interaction of the 46 kDa form with integrin αvβ3 was lowered 
(p = 0.062) (Figure III.17A). The overall amount of Shc, which was analyzed to control equal 
protein loading, was not change by these treatments (Figure III.17B). 
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Figure III.17: Elastase inhibition decreases shear stress-induced integrin αvβ3 activation 
(A) PAEC lysates of static cells, cells exposed to shear stress (16 dyn/cm², 60 minutes); cells exposed 
to shear stress with additional elastase inhibition (MEO: MeOSuc-Ala-Ala-Pro-Val-chloromethylketone, 
50 µM) were analyzed via coimmunoprecipitation (IP: integrin αvβ3, IB: Shc) (n = 4, mean + SEM, 
* p < 0.05 vs. static, # p < 0.05 vs. shear, ANOVA RM, Student-Newman-Keuls) or (B) as input control 
immunoblotted against Shc (n = 4). GAPDH was used to check equal protein loading. 
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It was further investigated whether the same effects as observed after shear stress could also 
be induced by elastase treatment. After exposing PAEC to porcine pancreatic elastase for 10 
minutes a significantly higher amount of all three Shc isoforms was associated with the 
integrin (elastase (10 min.) 44 kDa: 2.59 ± 0.61, 52 kDa: 1.71 ± 0.16 and 66 kDa: 3.28 ± 0.77 
fold over controls). This interaction was also observed after treatment with elastase for 30 and 
60 minutes (elastase (60 min): 46 kDa: 1.92 ± 0.52, 52 kDa: 1.61 ± 0.22 and 66 kDa: 3.88 ± 
0.90 fold over controls) (Figure III.18A). To exclude a change in the overall cellular content 
of Shc during elastase treatment, cell lysates were immunoblotted for this protein. In cells 
treated with pancreatic elastase the amount of all the three Shc isoforms did not change in 
comparison to untreated controls (Figure III.18B). 
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Figure III.18: Elastase induces the association of Shc and the integrin αvβ3 
PAEC were treated with porcine pancreatic elastase (0.5 U/ml) for the time indicated. (A) Lysates 
were subjected to immunoprecipitation (IP) with an αvβ3 antibody and immunoblotted (IB) for Shc 
(n = 3, mean + SEM, * p < 0.05 vs. control, ANOVA RM, Student-Newman-Keuls) or 
(B) immunoblotted for the Shc protein (n = 6). GAPDH was used as loading control. 
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5.2.3 Effects on focal adhesion points 
As integrins are directly linked to focal adhesions, the effect of porcine pancreatic elastase on 
focal adhesion kinase (FAK) and integrin-linked kinase (ILK), two prominent members of the 
focal contacts, was analyzed using confocal microscopy. In control cells both proteins were 
arranged as long thin fibers. Elastase caused the disappearance of these structures within 5 
minutes of stimulation. The focal structures reappeared after 10 minutes and exhibited a 
“dot”-like conformation. At the end of the observation period, after 60 minutes of elastase 
treatment, these “dots” were detectable in high frequency in ILK as well as in FAK staining, 
indicating a colocalization of both proteins (Figure III.19). Same alterations were detected in 
cells plated on collagen type I and on fibronectin. For better visualization large-size images of 
FAK in control cells and cells exposed to 5 or 60 minutes of elastase treatment are shown in 
Figure III.20, illustrating the three different states of FAK appearance. 
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Figure III.19: Elastase induces a rearrangement of focal adhesion sites 
Confocal microscope images of FAK and ILK in PAEC originally plated on collagen type I: Treatment 
with porcine pancreatic elastase (0.5 U/ml) induces a reorganization of focal adhesion points. The 
same effects and time course was observed in cells that were originally seeded onto fibronectin. Scale 
bar = 20 µm (63x objective, pixel size: 0.08 x 0.08 µm, z-step size: 0.25 µm, projection). 
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Figure III.20: FAK staining after elastase treatment 
Immunofluorescence large size images of FAK illustrate the different states of FAK appearance 
without and with elastase (0.5 U/ml). Scale bar = 20 µm (100x objective, pixel size: 0.16 x 0.16 µm). 
FAK is central regulator of integrin-mediated signaling. To check whether focal adhesion 
rearrangement was accompanied by changes in FAK activation, the tyrosine phosphorylation 
state of FAK was analyzed. In control cells Tyr397, Tyr576/577 and Tyr925 were 
phosphorylated. After 5 minutes of elastase treatment, these sites were, in comparison to 
control levels, dephosphorylated to a large extent and were rephosphorylated as analyzed 
between 10 to 60 minutes of ongoing elastase treatment (Figure III.21).  
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Figure III.21: Elastase alters FAK phosphorylation 
PAEC treated with elastase (0.5 U/ml) were immunoblotted to check FAK tyrosine phosphorylation at 
three independent sites: (A) Tyr397, (B) Tyr576/577 and (C) Tyr925. GAPDH was used as control for 
equal protein loading. A blot representative for three independent experiments is presented. 
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5.2.4 Effects of elastase on the cell cytoskeleton 
Focal adhesions directly link integrins to the cytoskeleton. Therefore we investigated the 
effects of porcine pancreatic elastase treatment on the cell cytoskeleton. The actin 
cytoskeleton was visualized using phalloidin (coupled to Alexa Fluor 488), a dye which labels 
F-actin. The integrin activation was indeed associated with cytoskeletal changes. Compared to 
control cells, cells treated with elastase showed a qualitatively higher density of stress fibers 
(see Figure III.22).  
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Figure III.22: Induction of stress fiber formation by elastase 
Fluorescent phalloidin staining (green), a F-actin marker, in two magnifications without (upper panel) 
and with additionally DAPI staining (blue) (lower panel) was observed in control cells (A, C) and cells 
treated with porcine pancreatic elastase (0.5 U/ml) for 60 minutes (B, D). DAPI was used to stain the 
cell nuclei. Images in the upper panel were taken with the confocal microscope (40x objective, pixel 
size: 0.12 x 0.12 µm, z-step size: 0.5 µm, projection), whereas those in the lower panel were taken 
with the fluorescence microscope (63x objective, pixel size: 0.1 x 0.1 µm). 
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5.3 INTRACELLULAR SIGNALING PATHWAYS INVOLVED IN ELASTASE 
INDUCED FGF-2 RELEASE 
5.3.1 Shear stress induces MAPK activation 
It has been shown that in endothelial cells exposed to shear stress MAP kinases are activated 9. 
In accordance with this, 120 minutes of shear stress application to PAEC resulted in an 
enhanced phosphorylation of p38, ERK1/2 and JNK1/2. This was observed in cells originally 
grown on collagen type I as well as on fibronectin. Under static conditions in cells seeded 
onto fibronectin MAPK were stronger phosphorylated than in cells seeded onto collagen 
type I, whereas after shear stress exposure the phosphorylation state was comparable for cells 
on both substrates (Figure III.23A). 
Inhibition of elastase with the specific elastase inhibitor MeOSuc-Ala-Ala-Pro-Val-
chloromethylketone or the unspecific elastase inhibitor chymostatin decreased the shear 
stress-induced p38 phosphorylation, whereas ERK1 and ERK2 activation was not reduced by 
elastase inhibition (Figure III.23B). 
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Figure III.23: MAPK are activated by shear stress 
(A) Static cells and cells exposed to shear stress were analyzed by using western blot (16 dyn/cm², 
120 minutes). Cells were originally seeded onto collagen type I (n = 6) or fibronectin (n = 3), 
respectively. (B) Elastase was inhibited using MeOSuc-Ala-Ala-Pro-Val-chloromethylketone (MEO, 
50 µM) or chymostatin (CHY, 10 µg/ml) (n = 4, cells originally seeded onto collagen type I). GAPDH 
was used as control for equal protein loading. 
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5.3.2 Elastase induces MAPK activation 
To investigate the effect of elastase on MAPK phosphorylation in detail, static cells were 
treated with porcine pancreatic elastase for different time periods and the cell lysates were 
analyzed by western blot. Elastase treatment activated all three MAPK. However, the extent 
of activation was dependent on the duration of exposure to elastase. The kinetics of 
phosphorylation differed between the different kinases: P38 and JNK phosphorylation 
increased throughout the observation period (after 60 minutes: p38: 4.2 ± 1.4, JNK1: 3.5 ± 0.7, 
JNK2: 3.3 ± 0.5 fold over controls). In contrast, ERK activation peaked at 10 to 30 minutes 
and almost returned to basal level after 60 minutes (after 10 minutes: ERK1: 2.0 ± 0.5, ERK2: 
2.4 ± 0.6 fold over controls, after 60 minutes ERK1: 1.4 ± 0.3, ERK2 1.6 ± 0.4 fold over 
controls) (Figure III.24 and Figure III.25). 
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Figure III.24: Elastase causes activation of p38 
Porcine pancreatic elastase treatment (0.5 U/ml) activates p38 (n = 6, mean + SEM, * p < 0.05 vs. 
control, 5 and 10 minutes elastase, ANOVA RM, Student-Newman-Keuls). Equal protein loading was 
controlled with p38. A representative blot of six separate experiments is presented. 
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Figure III.25: Elastase causes activation of ERK and JNK 
Porcine pancreatic elastase treatment (0.5 U/ml) activates (A) ERK1 (grey) and ERK2 (black) (n = 6, 
mean + SEM, * p < 0.05 vs. control, 5 and 60 minutes elastase) and (B) JNK1 (grey) and JNK2 (black) 
(n = 6, mean + SEM; * p < 0.05 vs. control, 5 and 10 minutes elastase, ANOVA RM, Student-
Newman-Keuls). Equal protein loading was controlled with GAPDH. A representative blot of six 
separate experiments is presented. 
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To study whether the elastase-induced FGF-2 release was dependent on this MAP kinase 
activation, they were blocked using three specific inhibitors. Whereas p38 and JNK inhibition 
significantly decreased the FGF-2 release to 57 ± 15% and 63 ± 17% respectively, ERK 
inhibition had no influence on the elastase-induced release of this growth factor (Figure 
III.26). 
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Figure III.26: P38 and JNK inhibition decrease elastase-induced FGF-2 release 
Under elastase treatment (porcine pancreatic elastase, 0.5 U/ml, 60 minutes), the p38 inhibitor 
SB202190 (SB), the MEK1/2 inhibitor U0126 (U0) or the JNK1/2 inhibitor SP600125 (SP) (10 µM each) 
were used. (A) FGF-2 release in cell supernatants was analyzed using an ELISA system and 
normalized to protein concentration. (n = 12, mean + SEM, * p < 0.05 vs. elastase, ANOVA RM on 
Ranks, Student-Newman-Keuls). (B) Western blotting of cell lysates was performed to control 
inhibitory effects of the pharmacological substances used. Phospho-ERK and phospho-JNK levels 
were directly downregulated by U0126 and SP600125. Since SB202190 does not block p38 
phosphorylation but its kinase activity, its downstream target Hsp27 was analyzed. Equal protein 
loading was controlled with GAPDH. 
5.3.3 Role of Hsp27 in FGF-2 release 
As shown before in our laboratory, elastase treatment induces the phosphorylation of Hsp27 
and its translocation to the cell membrane 107. To analyze a potential direct interaction of 
FGF-2 and Hsp27, coimmunoprecipitation experiments were performed. After 60 minutes of 
stimulation with porcine pancreatic elastase, a more than 3 fold higher amount of these two 
proteins was associated compared to untreated controls (3.3 ± 1.2 fold over control) (Figure 
III.27A). The overall amount of Hsp27 in these cell lysates was not affected by elastase 
treatment (Figure III.27B). Since the classical coimmunoprecipitation did not work reverse, 
sandwich ELISA experiments were performed, using the opposite order of the antibodies, 
namely an Hsp27 antibody as capturing and an FGF-2 antibody as detection antibody. Cells 
treated with 0.5 U/ml elastase showed a significantly increased interaction of FGF-2 and 
Hsp27 compared to controls (1.8 ± 0.1 fold over control) (Figure III.27C). 
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Figure III.27: Elastase induces an interaction of FGF-2 and Hsp27 
(A) PAEC were treated with porcine pancreatic elastase (0.5 U/ml). To analyze the interaction of 
FGF-2 and Hsp27, coimmunoprecipitation experiments of FGF-2 (IP) and Hsp27 (IB) were performed 
(n = 4, mean + SEM, * p < 0.05 vs. control, ANOVA RM, Student-Newman-Keuls). (B) The overall 
amount of Hsp27 was not changed in cell lysates used for coimmunoprecipitation as shown in western 
blots. Equal protein loading was controlled by staining blots with GAPDH. (C) PAEC treated with 
porcine pancreatic elastase (0.1 U/ml and 0.5 U/ml for 60 minutes) were analyzed by a sandwich-
ELISA using an Hsp27 antibody for capturing and an FGF-2 antibody for detection (n = 5, mean + 
SEM, * p < 0.05 vs. control, ANOVA RM on Ranks, Student-Newman-Keuls). 
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In order to study the direct involvement of Hsp27 in mediating the FGF-2 release, Hsp27 
expression was reduced by using siRNA oligonucleotides. Protein expression analysis with 
western blots (Figure III.28A) revealed that after 48 hours of transfection 92% less Hsp27 
protein was detected in these cells (data obtained by comparing band densities from 8 
independent experiments). Knockdown of Hsp27 in PAEC lowered the elastase-induced 
FGF-2 release about 30% compared to cells transfected with control siRNA (Figure III.28B). 
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Figure III.28: Hsp27 knockdown decreases elastase-induced FGF-2 release 
Cells were transfected either with control siRNA or Hsp27 siRNA (20 nM each). After 48 hours the 
medium was changed and cells were treated with porcine pancreatic elastase (0.5 U/ml) for 60 
minutes. (A) Hsp27 knockdown efficacy was controlled using western blots (n = 4). Equal protein 
loading was controlled by staining blots with GAPDH. (B) The quantity of FGF-2 released to the 
supernatant was measured by ELISA and normalized to the protein concentrations which were 
determined in the appropriate cell lysate (n = 24, mean + SEM, * p < 0.001, n.s. = not significant, 
ANOVA RM, Student-Newman-Keuls).  
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IV DISCUSSION 
The vasculature continuously undergoes remodeling not only in the embryo but throughout 
adult life. Vascular remodeling requires the formation of new vessels but also a permanent 
adjustment of existing vessels in response to functional needs. In the adult circulation, 
remodeling adapts vessels especially to changes in hemodynamic forces. Chronic changes in 
blood flow velocity and thus alterations in shear stress are one main stimulus for vessel 
remodeling and adaptation 41,206. 
1 AN ENDOTHELIAL ELASTASE AS MEDIATOR IN 
MECHANOTRANSDUCTION 
The present study extends previous work from our laboratory published by Gloe et al. and 
presented in the thesis of Christina Klarskov Mogensen. In 2002 Gloe et al. demonstrated that 
shear stress induces the release of FGF-2 from endothelial cells. This process was found to be 
specifically dependent on the integrin αvβ3 because inhibition of this integrin with RGD 
peptides or antibodies blocked the shear stress induced FGF-2 release, whereas inhibition of 
the integrin α5β1 had no effect on this process 75. In a follow up study, Klarskov Mogensen 
found a serine protease with elastase activity to be involved in the shear stress-induced FGF-2 
release 107. 
The current study extends these previous findings and identifies specific steps in the signaling 
cascade leading to shear stress-induced FGF-2 release. The main finding is that a not yet 
described elastase is released by shear stress leading to activation of the integrin αvβ3. Though 
it was not yet possible to identify the elastase, experiments with another isoform of the 
elastase family confirmed the specific role in the signaling process. 
 
The involvement of proteases in angiogenesis and vascular remodeling is well established. 
Protease inhibitors like α1-antitrypsin have been shown to inhibit angiogenesis 94. Marimastat 
was the first orally bioavailable MMP-inhibitor to have entered clinical trials in the field of 
oncology 160. MMP- and specific elastase inhibitors may also be effective in the remodeling 
of larger vessels as they were shown to induce a regression of pulmonary artery thickening in 
vivo 42. 
Few publications exist showing an influence of shear stress on protease activity. Those 
particularly examined the activity of MMPs and cathepsins. It was demonstrated that laminar 
shear stress increased MMP-2 and MMP-9 activity in porcine aortic valves whereas the 
activity and expression of cathepsin L was reduced in these valves as well as in endothelial 
cells 152,154. On the other hand, oscillatory shear stress was found to increase the release of 
cathepsin K from endothelial cells 153. These publications demonstrate that in principle, shear 
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forces can give rise to protease activity in the vascular wall in a rather specific manner and 
therefore might play a role in the mechanotransduction of shear stress. 
 
The current study demonstrates that the shear stress-induced endothelial FGF-2 release was 
reduced by specific elastase inhibition with MeOSuc-Ala-Ala-Pro-Val-chloromethylketone. 
Besides, a higher elastase activity was detected in shear stress supernatants using the specific 
substrate MeOSuc-Ala-Ala-Pro-Val-p-nitroaniline, which is cleaved by neutrophil and 
pancreatic elastase 32,134, but not by other proteases, like cathepsins or matrix 
metalloproteinases (MMPs), which as described above were found to be released from 
endothelial cells as well. Thus, the involvement of other proteases from the cathepsin- or 
MMP-family was excluded. Since the shear stress-induced FGF-2 release was also dependent 
on the integrin αvβ3 which, due to its interaction with the matrix and the cytoskeleton might 
act as a mechanosensor of shear stress, it was conceivable that the release of the elastase 
occurred as a result of the integrin activation. However, since the inhibition of the integrin by 
abciximab had no influence on the release of elastase, activation of the integrin αvβ3 is not a 
necessary step for the release of elastase. Rather, our findings suggest that an enzyme with 
elastase activity mediates the shear stress-induced integrin αvβ3 activation. 
In order to prove this hypothesis, cells were incubated with pancreatic elastase. Going in line 
with the shear stress experiments, the treatment with this exogenously applied elastase 
induced activation of the integrin αvβ3 and, probably as a consequence, release of FGF-2. This 
finding furthermore supported the idea of an elastase mediating the shear stress induced 
effects. 
 
The presence of enzymes with an elastolytic activity in the vessel wall has previously been 
reported: Endothelial cells as well as smooth muscle cells and fibroblasts were shown to 
synthesize elastolytic enzymes 113,129. Hornebeck et al. described an aortic elastase which 
exhibits an elastolytic activity similar to pancreatic elastase 92. None of these publications 
analyzed which particular enzyme was responsible for the activity measured. In this thesis we 
show that neither mRNA nor protein of neutrophil and pancreatic elastase is expressed in 
human and porcine endothelial cells. However, an antibody raised against neutrophil elastase 
was able to detect the endothelial elastase in western blot and immunofluorescence staining, 
suggesting that neutrophil and endothelial elastase possess structural similarities. The protein 
band that was observed in western blot exhibited a molecular weight in the range of 26 to 
29 kDa, similar to pancreatic and neutrophil elastase (pancreatic elastase: 27.8 kDa [Homo 
sapiens], 28.8 kDa [Sus scrofa], neutrophil elastase: 28.5 kDa [Homo sapiens] 171). We 
propose that a vascular elastase, a serine protease with elastase activity different from 
neutrophil and pancreatic elastase, but with homologies to neutrophil elastase, is expressed by 
and released from endothelial cells. The major evidence for this conclusion is the following: 
(1) susceptibility to specific elastase inhibitors, (2) cleavage of the specific elastase substrate 
and (3) appropriate molecular weight. 
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1.1 ELASTASE INDUCES AN ACTIVE RELEASE OF FGF-2 
As mentioned above, treatment of endothelial cells with pancreatic elastase led to a time-
dependent release of FGF-2. A similar pancreatic elastase-mediated release of FGF-2 was 
described by Buczek-Thomas. Based on their experiments in pulmonary fibroblasts, the 
authors postulated that FGF-2 is released by proteolytic digestion from proteoglycan storage 
sites in the extracellular matrix 22,23. They further demonstrated that the FGF-2 release 
correlated with the liberation of sulfated glycosaminoglycans and thereby concluded that 
elastase induces the release of extracellularly bound FGF-2 through disruption of matrix 
proteoglycans. In another study, Thompson and colleagues showed that neutrophil elastase 
releases FGF-2 from extracellular matrix storage sites of pulmonary smooth muscle cells 190. 
In contrast to these findings, Gloe et al. demonstrated that in response to shear stress FGF-2 
was released from the cytosolic pool of endothelial cells. At present it is difficult to reconcile 
these apparently contradictory findings. It is possible, that the amount of bound FGF-2 is 
much higher in the extracellular matrix and on the surface of fibroblasts and smooth muscle 
cells especially from the lung than in endothelial cells. In such a case, an additional release 
from inside the cells may be quantitatively smaller and therefore be overlooked. In the 
original experiments described by Gloe et al., a clear reduction of intracellular FGF-2 in 
response to shear stress was detected, indicating FGF-2 release from the cytosol 75. Moreover, 
if FGF-2 was only released from extracellular matrix storage sites it would be difficult to 
explain why this purely extracellular liberation process should be stopped by inhibition of the 
integrin αvβ3, by MAPK inhibition or by knockdown of Hsp27. The present thesis furthermore 
demonstrated that application of heparinase I, an enzyme that cleaves heparin and heparan 
sulfate proteoglycans 122 and has been shown to release extracellular matrix bound 
FGF-2 14,106, was not able to release FGF-2 in our setting. Therefore, the present data suggest 
that cytosolic FGF-2 is released by endothelial cells as a consequence of the complex 
signaling cascade described in this work. 
 
Engling et al. demonstrated that chinese hamster ovary (CHO) cells transfected with FGF-2 
release the growth factor continuously 56. The present study also reveals that a basal amount 
of FGF-2 at low levels is released under static conditions. In contrast to the findings in CHO 
cells, in our endothelial cells, the release of FGF-2 strongly increased after exposure to shear 
stress or external application of pancreatic elastase. This may be due to the different cell types 
used. While Engling et al. used CHO cells that are subcultivated for a long period of time, we 
used freshly isolated, primary endothelial cells. Moreover, cells transfected with FGF-2 may 
respond differently as cells that naturally express the protein. In our view, primary endothelial 
cells were a valid model to investigate conditions appearing in the intact vessel.  
 
As shear stress exerts a force on the cells, one can furthermore argue that cytosolic FGF-2 is 
set free as a result of cell damage, a mechanism that was suggested by several groups. This 
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can be excluded in the present setting, because experiments of Gloe et al. showed that shear 
stress of the magnitude and duration applied here did not result in membrane damage 75. 
Additionally, integrin inhibition would not block FGF-2 release if it was set free as a result of 
cell damage. 
Also, cells treated with elastase in a concentration of 0.5 U per ml, as used in the experiments 
performed here, did not show any sign of membrane damage. As demonstrated by Klarskov 
Mogensen, elastase treated cells were viable with intact cell membranes which was shown by 
negative staining for propidium iodide 107. Moreover, experiments performed in this study 
revealed no measurable release of lactate dehydrogenase after elastase treatment (data not 
shown). Thus, the release of FGF-2 must be a regulated and active process. 
 
We investigating whether elastase affects the de novo synthesis of FGF-2 and demonstrated 
that exposure of endothelial cells to pancreatic elastase had no effect on FGF-2 mRNA 
expression as assessed after 8 and 16 hours of elastase treatment. 
Comparing these results with data from the literature that analyzed the de novo synthesis of 
FGF-2 after shear stress, controversial results have been found. Application of shear stress of 
20 dyn/cm² increased FGF-2 expression as shown in porcine aortic endothelial and smooth 
muscle cells after 24 hours of stimulation 201. Investigating bovine aortic endothelial cells 
Malek et al. described only a mild but transient increase in FGF-2 mRNA levels at shear 
forces of 15 dyn/cm², whereas higher flow velocities of 32 dyn/cm² induced a significant 
increase after 6 hours 125. 
In vivo physical exercise, which is linked to increasing shear levels, was shown to increase 
FGF-2 expression in the hippocampus of rats after the fourth night of wheel running 76. By 
contrast, only 45 minutes of one-legged exercise in humans had no effect on FGF-2 mRNA 
levels 83. Finally, Deindl et al. demonstrated that, in arteriogenesis, a process with strongly 
increased shear levels, FGF receptor 1 expression levels increased in growing collateral 
arteries. However FGF-2 mRNA was not upregulated 49. 
1.2 INTRACELLULAR STORAGE OF ENDOTHELIAL ELASTASE 
As it was shown that an elastase mediates the shear stress-induced release of FGF-2, the 
intracellular storage sites of this enzyme in endothelial cells were further examined. In 
microglia an elastase or elastase-like protein was described which is secreted and detectable in 
the conditioned medium 135. For neutrophils it is well known that their elastase content is 
stored in intracellular azurophilic granules and liberated after activation of the cells.  
In endothelial cells, Weibel-Palade bodies, which allow for fast protein secretion in relative 
high amounts, are the main storage bodies. Previously it was demonstrated that shear stress 
induces the exocytosis of these Weibel-Palade bodies 67. The experiments presented here 
showed that vWF, the main content of these vesicles, colocalizes with elastase within the cell. 
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Furthermore, similar release kinetics of both these proteins were observed. Whereas the 
intracellular contents of vWF and elastase decreased after 240 minutes of shear stress 
application, the secreted amount increased. Therefore, the here presented observations are 
consistent with the hypothesis that both proteins are stored together in Weibel-Palade bodies 
and are released together in response to mechanical stimulation of endothelial cells by shear 
stress. 
It has to be mentioned that after 120 minutes of shear stress stimulation vWF and elastase 
were detectable outside the cells, whereas inside these cells no decrease in the amount of both 
proteins was measurable with western blots at this time point. This was probably due to the 
fact that only a small fraction of the overall protein content is released. The supernatant 
fraction was concentrated and therefore these amounts of protein were easier to measure. 
After 240 minutes of shear stress application the intracellular content of vWF and elastase 
measurably decreased compared to static cells. The parallel time dependencies in vWF and 
elastase release furthermore supported the idea of both proteins being released together.  
2 ELASTASE INDUCES INTEGRIN OUTSIDE-IN SIGNALING 
In 2002, Gloe et al. showed that integrin αvβ3 is strongly involved in the signaling process 
linking shear stress to FGF-2 release, since inhibition of the integrin αvβ3 blocked the shear 
stress induced release of FGF-2 75. 
The current study demonstrates that shear stress indeed induces integrin αvβ3 activation as 
assessed by the enhanced interaction of the integrin αvβ3 and its adaptor protein Shc. This 
association was reduced when incubating the cells with a specific elastase inhibitor, indicating 
that elastase is mediating the shear stress-induced integrin activation and again confirming 
that the integrin is located downstream of elastase in the signaling cascade. Furthermore, we 
showed that exogenously applied pancreatic elastase increased the interaction of the integrin 
αvβ3 and Shc as well. The time course observed here (significant activation after 10 minutes, 
that last till 60 minutes of stimulation) agreed with the one observed by Chen and colleagues 
after shear stress administration 36. In 2001, Jalali and coworkers already demonstrated that 
shear stress increased the association of the integrin αvβ3 and Shc in endothelial cells. 
Consistent with the role of elastase, cells plated on fibronectin and vitronectin for 2 hours 
showed integrin αvβ3 activation but not those grown on collagen type I or laminin 98. Tzima et 
al. also demonstrated that shear stress activates the integrin αvβ3 in endothelial cells using an 
independent method i.e. an antibody that selectively detects the activated integrin αvβ3 called 
WOW-1 194.  
 
Integrins can be principally activated by extracellular cleavage 178, phosphorylation, 
conformational changes, clustering or the exposure of new binding sites in the extracellular 
matrix. Integrin activation by direct proteolytic cleavage was excluded in our system, because 
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exposure to elastase did not alter the size of the integrin αv subunit, and therefore did not 
cleave the integrin (Gloe, unpublished data). Moreover elastase had no effect on FGF-2 
release when acting on endothelial cells in suspension 107. 
The ability of proteases to generate integrin-mediated intracellular signals by remodeling the 
matrix has previously been demonstrated 57. To investigate the effect of elastase on the 
macrostructure of the extracellular matrix, different matrix proteins were incubated with 
pancreatic elastase. Since the capability of elastases to degrade elastin is well known, this was 
not investigated in this study. Pancreatic elastase was found to degrade fibronectin, laminin 
and vitronectin, whereas collagen type I and IV were not affected. Data from the literature 
showed a comparable but slightly different activity for neutrophil elastase: It cleaves 
fibronectin and laminin but also collagen type IV 51,86,127,200. In the case of collagen type I 
contradictory results exist. Whereas Kafienah proposed neutrophil elastase to be capable of 
degrading this collagen 102, the group around Dunsmore showed that total lung collagen was 
not increased in neutrophil elastase-deficient mice 52. Therefore the degradation profile of the 
two elastolytic enzymes seems to differ especially in their effect on collagens. Since human 
neutrophil elastase and porcine pancreatic elastase are 43% homologue, these different 
degradation properties may be explained by changes in several residues 179.  
Since in our study the activation of the integrin αvβ3 was investigated, the influence of 
elastase on major integrin αvβ3 ligands was most interesting. The integrin serves as receptor 
for RGD-containing proteins, predominantly vitronectin, fibronectin, laminin and fibrinogen 
37,93. By contrast, attachment of this integrin to collagens has not been described. Orr et al. 
demonstrated that flow induced the activation of the integrin αvβ3 only in cells grown on 
fibronectin or fibrinogen, but not on collagen type I 142. Moreover, Cai and colleagues 
demonstrated that cells grown on fibronectin expressed high levels of integrin αvβ3 and α5β1 
as well as FAK and phospho-FAK (Tyr397), whereas cells cultured on laminin express lower 
levels of FAK and the integrins 28. Thus, we suggest that the integrin αvβ3 is activated by only 
a few matrix components including fibronectin. 
 
Immunofluorescence experiments revealed that the effect of pancreatic elastase on fibronectin 
was most prominent, compared to other extracellular matrix components. Whereas the 
macrostructure of vitronectin and laminin matrices was only slightly changed, the 
extracellular fibronectin network almost completely disappeared after elastase treatment. 
Similar, but less pronounced effects were detected after the application of shear stress 
supernatant containing endothelial elastase, or direct exposure to shear stress. Other groups 
showed that after 12 hours of shear stress exposure, using 24 or 30 dyn/cm², respectively, 
fibronectin levels in the extracellular matrix were lower than in static controls 82,191. This may 
also be explained by the mechanisms described here i.e. due to proteolytic degradation of 
matrix fibronectin by elastase. 
Furthermore it was shown here that fibronectin fragments are released to the supernatant by 
pancreatic elastase stimulation. For neutrophil elastase McDonald et al. demonstrated that 
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incubation of fibronectin with this enzyme produced biologically active fragments with cell-
adhesive and gelatin-binding activity 127. Moreover, Loeser et al. demonstrated in 
chondrocytes that a 120 kDa fibronectin, a chymotryptic fragment, as well as a 110 kDa 
fibronectin fragment are able to activate the ERK1/2, JNK and p38 MAP kinase 63,124. 
Henriksen and coworkers provided evidence that the action of neutrophil elastase on elastin, 
collagen, fibronectin and proteoglycans exposes new recognition sites that bind integrins 89. 
In the current study three different modes of integrin αvβ3 activation have to be considered: 
(1) direct integrin activation by fibronectin fragments, (2) exposure of new laminin, 
vitronectin or fibronectin binding sites that directly activate integrins or (3) alterations of the 
macrostructure of the matrix that may provoke integrin (re-)clustering or conformational 
changes and thereby, indirectly, their activation. 
 
Girard and colleagues demonstrated that the integrin αvβ3 is present in focal contacts 73. Focal 
adhesion activation provides a mechanism for integrins to transduce signals from the 
extracellular matrix into the cell. The most definitive evidence that FAK, the most prominent 
member of focal adhesions, is directly downstream of signals initiated by the extracellular 
matrix is the finding, that the phenotype of FAK null-embryos strongly resembles that of 
fibronectin deficient mice. They both display almost identical vascular defects 96. These 
similarities supported the idea that FAK and fibronectin are part of the same signaling 
pathway.  
Several reports demonstrated that shear stress influences the arrangement of focal 
adhesions 47,73,176. Shikata and colleagues showed that in endothelial cells exposed to shear 
stress, focal adhesions are redistributed and accumulate in the cell periphery 176. Galbraith and 
coworkers furthermore demonstrated that this redistribution allows the endothelial cells to 
remain attached in the face of the fluid force 66.  
To further evaluate the role of focal contacts in our setting, the effect of elastase on these 
adhesion points was investigated. Own experiments with pancreatic elastase demonstrate that 
focal contacts, as assessed by ILK and FAK staining, were reorganized after treatment with 
pancreatic elastase. Under basal conditions focal contacts appeared as thin fibers whereas 
after 60 minutes of elastase stimulation the spatial structure of these focal adhesions appeared 
completely different. They now appeared as big pronounced dots which were situated mainly 
in the cell periphery. In between these two events, after 5 minutes of stimulation, the FAK 
and ILK staining in the cell periphery vanished almost completely. The different appearance 
of the focal contacts before and after stimulation may be due to different matrix-integrin 
interactions. This conclusion is consistent with findings of Honore et al., who showed that, 
depending on the matrix composition and the specific integrin, focal points appear quite 
different 90. When examining FAK phosphorylation, we observed a time-course similar to that 
in immunofluorescence experiments on focal adhesion changes. The basal as well as the 
activated state were characterized by FAK phosphorylation, whereas in the meantime the 
protein was dephosphorylated.  
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Based on these findings the following model of focal adhesion activation is proposed. In 
untreated controls FAK has a constitutive basal activity, which may allow for the association 
to integrins and therefore their anchoring to the extracellular matrix, providing cell adhesion. 
Direct elastase stimulation leads to changes in the matrix and activates the integrin αvβ3, 
which results in FAK activation, focal adhesion assembly and reorganization. This may on the 
one hand increase cell matrix adhesion which stabilize the cells and on the other hand induce 
intracellular signaling. As already mentioned, in between the basal and activated state FAK 
was dephosphorylated. By investigating this state with immunofluorescence experiments we 
found that the FAK/ILK focal contacts were disappeared in the cell periphery. However, cells 
stayed attached, indicating that at this point cells may be connected to the matrix via other 
structures than FAK and ILK composing focal adhesions. 
Tzima et al. showed a similar biphasic regulation of Rho activity after shear stress treatment. 
They observed a decrease in Rho activity after 5 to 15 minutes of shear stress that was 
followed by an increase which peaked at 60 minutes 194. This is interesting since Rho is a key 
regulator of the actin cytoskeleton and strongly implicated in the formation of stress fibers 6,85. 
This protein can be activated by integrins inducing maturation of cell contacts to form actin 
stress fibers, with associated increases in FAK activity 173. Therefore Rho and FAK activity 
might be linked together, explaining the identical activation profile after shear stress or 
elastase application, respectively. 
 
Focal adhesions are directly connected to the actin cytoskeleton. Activation of FAK can lead 
to actin remodeling and stress fiber formation 71. The development of stress fibers in cultured 
endothelial cells exposed to shear stress has been demonstrated by several groups 65,126,138. 
That is why we investigated the effect of elastase on F-actin. Endothelial cell stimulation with 
pancreatic elastase induced the formation of stress fibers. It remains elusive, however, by 
which signaling pathway this may be transduced. As Rho activation has been directly linked 
to stress fiber formation, the effect could be directly induced by Rho activation. Alternatively, 
as has been published before, p38 and Hsp27 could be involved in actin polymerization and 
cytoskeletal remodeling 149, both proteins being activated after elastase treatment in our 
experiments. Therefore stress fiber formation may alternatively, or in addition, be a 
consequence of MAPK and Hsp27 activation. 
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3 INTRACELLULAR SIGNALING CASCADES INVOLVED IN FGF-2 
RELEASE 
Whereas the biological functions of FGF-2 are well characterized 139, the mechanisms leading 
to its release remain elusive. Also, the release mechanism itself is unclear, since FGF-2 lacks 
a signal sequence needed for classical protein secretion via the endoplasmic reticulum and 
Golgi apparatus. The following chapter will focus on some of the intracellular mechanisms 
involved in FGF-release as assessed in this work. 
3.1 MAPK PATHWAYS INVOLVED IN FGF-2 RELEASE 
In this study, we demonstrate that shear stress exposure activates all three main MAPK, which 
are p38, ERK and JNK. Furthermore, it was demonstrated that elastase inhibition reduced the 
shear stress-induced p38 activation, whereas ERK activation was not inhibited. 
Christina Klarskov Mogensen showed that cell stimulation with pancreatic elastase for about 
60 minutes induced p38 activation whereas ERK phosphorylation was not affected at this 
time 107. The experiments performed in this study extended these data analyzing the time 
course of MAPK activation after 5, 10, 30 and 60 minutes of elastase stimulation. These 
experiments show that not only p38 but also ERK and JNK are activated by elastase although 
they exhibit different activation kinetics. Whereas p38 and JNK were maximally activated 
after 60 minutes; ERK activation peaked already at 10 to 30 minutes to reach control levels 
again after 60 minutes of stimulation, which explains why Klarskov Mogensen did not detect 
ERK activation. Data from the literature revealed similar time courses of MAPK activation 
after shear stress application. Li and coworkers demonstrated that maximal ERK 
phosphorylation is reached earlier than p38 and JNK activation, which peaked around 20 
minutes later 120.  
To test which of these kinases is involved in FGF-2 release, inhibitors were used that 
specifically block each MAPK pathway (see Figure I.13). While inhibiting p38 and JNK 
significantly reduced FGF-2 release, blocking ERK did not alter the amount of FGF-2 
secreted in response to elastase treatment. Thus the experiments presented here, demonstrated 
that only p38 and JNK play a role in the process of shear stress-induced FGF-2 release. 
As it was shown by several groups that inhibition of the integrin αvβ3 blocked the shear stress-
induced activation of p38, ERK and JNK 98,114,118, it is reasonable to argue that flow-induced 
MAPK phosphorylation is mediated via this integrin. This is further supported by previous 
findings of our laboratory, which demonstrated that elastase-induced p38 activation can be 
blocked with the integrin αvβ3 blocker abciximab 107. This is also in accordance with results 
reported by Chen et al. showing that inhibition of αv integrins or downregulation of their 
expression decreased active levels of p38 35. The precise signaling pathway connecting the 
integrin and MAP kinase activation is still elusive in our setting. However, since shear stress 
and elastase stimulation induced the association of the integrin αvβ3 with its adaptor protein 
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Shc and, in addition to that, the formation of new focal adhesion points, downstream signaling 
may be transduced via Shc or focal contact proteins like FAK (see Figure I.11). 
3.2 INVOLVEMENT OF HSP27 IN FGF-2 RELEASE 
Heat shock proteins are molecular chaperones that are required for protein folding. Wesche et 
al. provided evidence that the Hsp90 molecule is crucial for the translocation of FGF-1 and 
FGF-2 from endosomes into the cytosol 202, indicating that this class of proteins may be 
involved in protein translocation. Piotrowicz and colleagues proposed that the Hsp27 protein 
facilitates the release of FGF-2 from bovine aortic endothelial cells by interacting with it. 
They demonstrated that the expression of Hsp27 doubled the rate of FGF-2 secretion, whereas 
a decrease in the endogenous Hsp27 level decreased FGF-2 release 150. Morover, Cao et al. 
showed that the thrombin-induced release of FGF-2 is reduced by Hsp27 knockdown 30. 
Therefore the role of Hsp27 in elastase-induced FGF-2 release was further examined. 
 
In the present work the association of FGF-2 and Hsp27 was investigated after elastase 
stimulation using two different approaches, on the one hand a coimmunoprecipitation assay 
and on the other hand an ELISA. It was shown that after 60 minutes of elastase treatment the 
association of the two proteins was significantly increased compared to untreated controls. In 
addition, to clarify whether Hsp27 is necessary for the release of FGF-2, Hsp27 knockdown 
experiments were performed. This knockdown reduced FGF-2 release by 30%. Therefore 
Hsp27 has been shown to play a significant role in FGF-2 release, but the reduction of FGF-2 
release was limited. Two explanations come into consideration to account for the incomplete 
reduction of FGF-2 release. Firstly, the release of FGF-2 via Hsp27 may not be the only 
pathway and other mechanisms or molecules additionally or alternatively facilitate the release. 
Secondly, as the knockdown experiments did not totally eliminate Hsp27 expression (about 
8% of the Hsp27 protein were still expressed), the small amount left may be sufficient to 
allow for the remaining release of FGF-2.  
The involvement of Hsp27 in FGF-2 release has already been investigated by Christina 
Klarskov Mogensen in our laboratory. She demonstrated that shear stress exposure as well as 
treatment with pancreatic elastase induced a translocation of FGF-2 and Hsp27 to the cell 
membrane with similar time courses. Furthermore, she showed that both kinds of treatment 
led to Hsp27 phosphorylation. This happened in an integrin αvβ3 and p38 dependent manner, 
because pretreatment with abciximab or SB202190 blocked Hsp27 phosphorylation under 
these conditions 107.  
Summarizing the here presented novel data and previous findings from Klarskov Mogensen, 
it can be concluded that elastase stimulation induces the formation of a complex of FGF-2 and 
Hsp27 that translocates to the membrane. Therefore we propose that the Hsp27 molecule 
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assists the cellular transport of FGF-2 towards the membrane and therefore is one important 
factor facilitating the release of FGF-2.  
These findings were supported by data from the literature showing that the same stimuli that 
lead to a release of FGF-2 also lead to Hsp27 phosphorylation (see chapter I.3.4.1 and I.4.2), 
indicating that Hsp27 is not only required for the release of FGF-2 during shear stress but for 
multiple other stimuli. Whether the heat shock protein is also required for the passage of 
FGF-2 through the membrane is still unclear. 
4 IMPLICATIONS OF FGF-2 ON VASCULAR REMODELING 
Application of recombinant FGF-2 has been shown to increase angiogenesis and 
arteriogenesis in experimental in vivo models 11. Factors that lead to the release of FGF-2 may 
therefore facilitate developmental processes, angiogenesis or vascular remodeling. Shear 
stress induces the release of FGF-2 from endothelial cells as shown by Gloe et al. in vitro and 
by Lepidi et al. from veins in vivo 75,115.  
Exercise training is a physiological situation with at least temporarily elevated shear levels. 
Accordingly, it was demonstrated that circulating FGF-2 is enhanced acutely after maximal 
exercise 29 and chronically after 6 months of exercise training 174. Jensen el al. showed that 
exercise training induces capillary growth and a transient proliferation of endothelial cells 
within 4 weeks, and therefore stimulates angiogenesis, but they did not relate their findings to 
FGF-2 release 100. However, the findings of enhanced FGF-2 release are not conclusive since 
other groups reported no change 79 or even a decrease in FGF-2 levels 54 after exercise.  
FGF-2 does not only support angiogenesis but also vascular remodeling in arteriogenesis. It is 
proposed that FGF-2 released from cells of the vessel wall attracts and activates monocytes, 
which then in turn supply FGFs to the growing collateral arteries and thereby promote 
arteriogenesis in a paracrine manner 49. Bryant et al. identified FGF-2 as an important factor 
in vascular remodeling, not only regulating vascular tone but also inward remodeling, as 
antibodies against FGF-2 attenuated inward remodeling in a mouse model of carotid artery 
flow cessation 21. However, lack of FGF-2 in mice did not affect structural remodeling of 
large arteries in response to chronically altered blood flows and had furthermore no effect on 
angiogenesis and arteriogenesis after femoral artery ligation 183,184. 
The results of the presented study implicate that higher levels of shear forces caused by 
exercise training or in arteriogenesis may be linked to increasing levels of FGF-2 in the vessel. 
Thus, FGF-2 signaling is induced, which increases cell proliferation, migration and 
differentiation and thereby contributes to vascular remodeling processes. 
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5 LIMITATIONS OF THE STUDY 
All experiments presented here were performed using primary endothelial cells, most assays 
with porcine endothelial cells (PAEC) and some using human endothelial cells (HUVEC). 
Usage of human cells throughout the whole study was impractical due to limited access to 
umbilical cords and slow growing properties of these cells. By contrast, PAEC were available 
in higher quantity, easier to handle, less susceptible and growing much faster. Moreover, 
arterial endothelial cells corresponded better to our model than venous cells. Due to high 
protein sequence homologies between human and pig, most antibodies raised against the 
protein of human origin also detected the porcine one. Only the vWF ELISA did not work 
with porcine cells, therefore the assay was performed using HUVEC. 
As mentioned before, the two types of endothelial cells used here differ in their vessel origin: 
PAEC are arterial endothelial cells, HUVEC are venous endothelial cells. The data from Gloe 
et al. were obtained using HUVEC 75. In contrast, Klarskov Mogensen’s data and the data 
presented here were obtained mainly studying PAEC 107. As experiments with the two cell 
types, produced comparable results, we would suggested that the mechanisms for FGF-2 
release proposed here can be found in arterial and venous vessels to the extent that cultured 
cells represent their tissue of origin. However, as arteries and veins do not only vary in 
diameter and structure, but also in their function, it is hard to compare them, especially due to 
the fact that venous endothelial cells under physiological circumstances are hardly exposed to 
shear stresses exceeding 6 dyn per cm² and were therefore exposed to “non-physiological” 
levels in this case. 
 
The shear stress applied here was within a range that can be observed in small arteries and 
therefore reflects a relevant physiological level especially with respect to arteriogenesis. 
However, it must be stated that only short-term effects of elevated shear stress were analyzed 
here. Therefore it is not possible to conclude that chronic shear stress still maintains a chronic 
level of elastase release and the subsequent signaling cascade or whether the cascade of 
events described here always requires a major change of the actual shear stress. 
The use of static endothelial cells as controls does not reflect a physiological situation, 
because in vivo endothelial cells are continuously exposed to blood flow. However, a system 
which allows the long-term application of shear stress limits the experimental capacity 
considerably and was, therefore, not available for this study. Therefore, we cannot exclude 
that comparing different levels of shear stress would yield the same results as comparing no 
shear stress with arterial shear stress. 
 
Although this study showed that a new type of elastase is expressed in endothelial cells, its 
identity and therefore its structure is not yet known. With one of the antibodies the enzyme 
was detected in western blot. Moreover, immunofluorescence experiments and electron 
microscopy were performed in search of intracellular localization. Protein purification 
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techniques such as immunoprecipitation followed by mass spectrometry are going to be 
applied but will not contribute to the results of the present manuscript due to time constraints. 
Since the endothelial elastase was not identified here, we were forced to use another enzyme 
that also exerts an elastolytic activity for experiments with elastase stimulation. Therefore we 
used porcine pancreatic elastase. Although this enzyme might not have a completely identical 
substrate spectrum, we obtained comparable results when using shear stress and exogenously 
applied pancreatic elastase (see Table IV.1). Overall the same signaling cascades were 
activated by both stimuli. Therefore we propose that the activities of endothelial elastase and 
pancreatic elastase are comparable with regard to our model. 
 
Regarding the specificity of elastase, it seemed an obvious approach, to investigate whether 
the shear dependent activation of the intracellular signaling cascades depends on various 
specific protein matrices. Since, as mentioned before, fibronectin but not collagen type I is a 
ligand of integrin αvβ3 and a substrate for pancreatic elastase, cells were grown on glass plates 
coated with either collagen type I or fibronectin for 24 hours. However, cells originally 
seeded on collagen type I had secreted significant amounts of fibronectin within this time 
period, thereby changing the composition of the extracellular matrix. Thus, all effects which 
were observed in cells originally grown on collagen type I, may as well be a consequence of 
fibronectin signaling. 
However, our idea of shear stress being mediated via fibronectin, was recently supported by 
Hahn et al., who demonstrated that cells seeded onto fibronectin showed a marked increase in 
JNK phosphorylation in response to flow, whereas cells on collagen type I showed no 
activation compared to static controls 84. They, in contrast to us, performed their experiments 
after 4 hours of seeding time. Indeed, cells in our system had not been highly adherently and 
confluent after 4 hours of seeding time, which is why we performed shear stress experiments 
later. 
 
Lastly, for a more accurate prediction of the results obtained in endothelial cell cultures in 
vitro, they need to be verified with an in vivo model, for example using an exercise or an 
arteriogenesis model, processes that involve increasing blood velocities. 
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Table IV.1: Comparison of results obtained after shear stress exposure and application of 
pancreatic elastase including the specific reference 
Treatment 
 
Shear stress exposure 
(16 dyn/cm²) 
Elastase treatment 
(0.5 U/ml) 
 
Effect 
Result Figure/ 
Reference 
Result Figure/ 
Reference 
FGF-2 release Increase Figure III.2 Increase Figure III.10 
+ elastase inhibition Reduction Figure III.2 -----------  
+ integrin αvβ3 inhibition Reduction Figure III.2 Reduction Klarskov, 2006 
FGF-2 cell surface 
localization 
Increase Klarskov, 2006 Increase Klarskov, 2006 
+ integrin αvβ3 inhibition Not tested  Reduction Klarskov, 2006 
FGF-2 expression Slight increase Chien, 1998 No effect Figure III.11 
Fibronectin degradation Slight 
restructuring 
Figure III.15 
Orr, 2006 
Degradation Figure III.14 
Figure III.15 
Interaction of integrin αvβ3 
and Shc 
Increased 
interaction 
Figure III.17 Increased 
interaction 
Figure III.18 
+ elastase inhibition Reduction Figure III.17 ----------  
Focal adhesion 
rearrangement 
Rearrangement Davies, 1994 
Girard, 1995 
Shikata, 2005 
Rearrangement Figure III.19 
Figure III.20 
Figure III.21 
Stress fiber formation Increase Franke, 1984 
Malek, 1996 
Noria, 2004  
Increase Figure III.22 
p38 phosphorylation Increase Figure III.23A Increase Figure III.24 
+ elastase inhibition Reduction Figure III.23B ----------  
+ integrin αvβ3 inhibition Not tested  Reduction Klarskov, 2006 
ERK phosphorylation Increase Figure III.23A Increase Figure III.25A 
JNK phosphorylation Increase Figure III.23A Increase Figure III.25B 
Hsp27 in membrane 
fraction (translocation) 
Increase Klarskov, 2006 Increase Klarskov, 2006 
+ integrin αvβ3 inhibition Not tested  Reduction Klarskov, 2006 
+ p38 inhibition Not tested  Reduction Klarskov, 2006 
Hsp27 phosphorylation Increase Klarskov, 2006 Increase Klarskov, 2006 
+ integrin αvβ3 inhibition Not tested  Reduction Klarskov, 2006 
+ p38 inhibition Reduction Azuma, 2001 Reduction Klarskov, 2006 
Interaction of Hsp27 and 
FGF-2 
Not tested  Increased 
interaction 
Figure III.27 
Hsp27 Knockdown Not tested  Reduction of 
FGF-2 release 
Figure III.28 
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V SUMMARY 
Chronic elevation of shear stress is considered to be one of the most powerful stimuli for 
vascular remodeling, which requires control of cell proliferation, migration and differentiation, 
events that are known to be regulated by growth factors. Fibroblast growth factor-2 (FGF-2) 
which is stored within the endothelium has been shown to be released from cells exposed to 
shear stress. 
The objective of the present study was to identify and characterize the mechanisms of shear 
stress-induced FGF-2 release in endothelial cells, regarding integrin outside-in signaling and 
intracellular signaling pathways. 
Using cultured porcine aortic endothelial cells (PAEC), which were exposed to arterial levels 
of laminar shear stress, we showed that shear stress was associated with the appearance of an 
elastase activity in the supernatant. Activation of the integrin αvβ3 was not necessary for the 
release of elastase; however, the integrin was indispensable for the shear stress-mediated 
FGF-2 release, suggesting that the integrin αvβ3 activation is downstream of the elastase 
release. As specific inhibition of elastase activity prevented FGF-2 release, we propose that an 
elastase mediates the shear stress-induced FGF-2 release. This endothelial elastase, a serine 
protease with elastase activity, differs from the hitherto described elastases – neutrophil and 
pancreatic elastase – since both elastases could not be detected by RT-PCR in PAEC. The 
enzyme colocalized with von Willebrand factor, indicating that endothelial elastase is stored 
in the Weibel-Palade bodies. As the molecular structure of this enzyme is still not known, 
knockdown experiments were not possible. Instead, we studied the effect of exogenously-
applied pancreatic elastase to further clarify the effects of an elastase on FGF-2 release. In 
fact, treatment with porcine pancreatic elastase resulted in a FGF-2 release from static cells 
similar to that induced by shear stress. Pancreatic elastase induced extracellular matrix 
alterations, thereby affecting vitronectin, laminin and especially the extracellular 
macrostructure of fibronectin. Similar effects were observed after exposing matrix layers to 
the elastase-containing supernatant of PAEC exposed to shear stress. Elastase treatment 
further resulted in activation of the integrin αvβ3 and reorganization of focal adhesion sites, 
indicating an active outside-in signaling. The latter could be linked to activation of the 
MAP kinases p38 and JNK as well as the downstream p38 target Hsp27. 
Since we could show that both stimuli – shear stress and exogenously applied elastase – 
activate the same signaling pathway, the following model is proposed: Elastase, which is 
released from the endothelium as a consequence of shear stress exposure, alters extracellular 
matrix components, among them fibronectin, a ligand for αvβ3, thereby inducing a remodeling 
of the matrix’s macrostructure. As a consequence, the integrin αvβ3 is activated, and focal 
adhesions rearrange to build newly organized focal contacts. This is a signal to activate the 
MAP kinases p38, ERK and JNK. However, only p38 and JNK phosphorylation is necessary 
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for the release process of FGF-2. This cascade ultimately leads to the interaction of Hsp27 
with FGF-2, thereby facilitating the release of the growth factor (see Figure V.1). 
In summary, we present a new model for the transduction of shear stress into extracellular 
matrix-dependent signals, integrin outside-in signaling and FGF-2 release via a novel 
endothelial elastase. The cascade presented here may represent a necessary initial step in the 
adaptive remodeling process induced by shear stress. 
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Figure V.1: The model for shear stress-induced FGF-2 release 
(A) Step 1: Shear stress induces the release of endothelial elastase, which induces structural changes 
in the ECM. (B) Step 2: Integrin outside-in signaling is induced and intracellular signaling cascades are 
activated. (C) Step 3: FGF-2 is released. Hsp27 facilitates this process. 
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VII APPENDIX 
1 ABBREVIATIONS 
A    Ampere 
A    Area 
A   Adenine 
ABC    Abciximab 
AG    Aktiengesellschaft 
Ala    Alanine 
Ang    Angiopoetin 
ANOVA RM Analysis of variance between groups for repeated measures 
APS Ammonium persulfate 
AT Annealing temperature 
ATF Activating transcription factor 
ATP Adenosine triphosphate 
b    Width 
BCA    Bicinchoninic acid 
bFGF    Basic fibroblast growth factor 
bp    Base pair 
BSA    Bovine serum albumin 
BSA-c    Bovine serum albumin (acetylated) 
C    Celsius 
c    Centi 
C    Cytosine 
CCD    Charge-coupled device 
CD    Cluster of differentiation 
cDNA    Complementary DNA 
CHO    Chinese hamster ovary 
CHY    Chymostatin 
Co.    Company 
COL    Collagen 
D    Aspartic acid 
Da    Dalton 
DAPI    4’,6-Diamidino-2-phenylindole 
DMEM    Dulbecco’s modified eagle’s medium 
DMSO    Dimethyl sulfoxide 
DNA    Deoxyriblonucleic acid 
dNTPs    Deoxynucleoside triphosphates 
dsDNA    Double-stranded DNA 
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dsRNA    Double-stranded RNA 
ECM    Extracellular matrix 
EDHF    Endothelium-derived hyperpolarizing factor 
EDTA    Ethylenediaminetetraacetic acid 
EGF    Epidermal growth factor 
ELA    Elastase 
ELISA    Enzyme-linked immunosorbent assay 
eNOS    Endothelial nitric oxide synthase 
ER    Endoplasmic reticulum 
ERK    Extracellular signal-regulated kinases 
et al.    Et alii/et aliae 
F    Force 
FACS    Fluorescence-activated cell sorting 
FAK    Focal adhesion kinase 
FAT    Focal adhesion targeting 
FCS    Fetal calf serum 
FERM    Protein 4.1, ezrin, radixin, moesin homology 
FGF    Fibroblast growth factor 
FGFR    Fibroblast growth factor receptor 
FITC    Fluorescein isothiocyanate 
FL2-H    Fluorescence channel 2 height (bandpass 585/42 nm) 
FN    Fibronectin 
FSC-H    Forward scatter height 
G    Glycine 
g    Gram 
G    Guanine 
G    Units of gravity 
GAPDH    Glyceraldehyde-3-phosphate dehydrogenase 
GFP    Green fluorescent protein 
GmbH    Gesellschaft mit beschränkter Haftung 
GM-CSF    Granulocyte-macrophage colony-stimulating factor 
Gp    Glycoprotein 
Grb    Growth factor receptor-bound protein 
h    Height 
h    Hour 
h    Planck constant 
HEP    Heparinase 
hMNZ    Human mononuclear cells 
HRP    Horseradish peroxidase 
HSA    Homo sapiens 
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Hsp    Heat shock protein 
HSPG    Heparan sulfate proteoglycans 
HTCR    Human tissue and cell research 
HUVEC    Human umbilical vein endothelial cells 
IB    Immunoblot 
ICAM    Intercellular adhesion molecule 
Ig    Immunoglobulin 
IL    Interleukin 
ILK    Integrin-linked kinase 
Inc.    Incorporated 
IP    Immunoprecipitation 
JNK    C-jun N-terminal kinases 
k    Kilo 
KGaA    Kommanditgesellschaft auf Aktien  
l    Liter 
LAMP    Lysosomal-associated membrane protein 
LM    Laminin 
log    Logarithm 
Ltd.    Limited 
m    Meter 
m    Milli 
M  Molar 
MAPK    Mitogen-activated protein kinases 
MAPKAPK  Mitogen-activated protein kinase activated protein kinase 
MAPKK    Mitogen-activated protein kinase kinase 
MAPKKK    Mitogen-activated protein kinase kinase kinase 
MCP    Monocyte chemoattractant protein 
MEK    MAPK/ERK kinase 
MEKK    MAPK/ERK kinase kinase 
MEO    MeOSuc-Ala-Ala-Pro-Val-chloromethylketone 
MeOSuc    Methoxysuccinyl 
min    Minutes 
MMP    Matrix metalloproteinase 
mRNA    Messenger ribonucleic acid 
n    Nano 
N    Newton 
n    Number of individual measurements 
n.s.    Not significant 
NA    Numerical aperture 
NCBI    National center for biotechnology information 
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NE    Neutrophil elastase 
NO    Nitric oxide 
p    Phospho 
p    Pico 
PAEC    Porcine aortic endothelial cells 
PAK    P21-activated kinase 
PBS    Phosphate buffered saline 
PCR    Polymerase chain reaction 
PDGF    Platelet-derived growth factor 
PE    Phycoerythrin 
PECAM    Platelet endothelial cell adhesion molecule 
PI3K    Phosphoinositide-3-kinase 
pMNZ    Porcine mononuclear cells 
PMSF    Phenylmethylsulfonyl fluoride 
PMT    Photomultiplier tube 
pNA    Para-nitroaniline 
PPE    Porcine pancreatic elastase 
Pro    Proline 
PRR    Proline-rich region 
PtdIns(3,4,5)P3  Phosphatidylinositol-3,4,5-triphosphate 
Q    Flow rate 
R    Arginine 
r    Vessel radius 
RGD    Arginine-glycine-aspartic acid 
RISC    RNA-induced silencing complex 
RNA    Ribonucleic acid 
RNAi    RNA interference 
rRNA    Ribosomal ribonucleic acid 
RTK    Receptor tyrosine kinase 
RT-PCR    Reverse transcription-PCR 
s    Seconds 
S    Svedberg 
SAPK    Stress-activated protein kinase 
SB    SB202190 
SDS    Sodium dodecylsulfate 
SDS-Page    Sodium dodecylsulfate-polyacrylamide gel electrophoresis 
SEM    Standard error of the mean 
Ser    Serine 
SFK    Src family kinase 
SH2    Src homology 2 
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Shc    Src homology 2 domain-containing transforming protein 
siRNA    Small interfering RNA 
SOS    Son of sevenless 
SP    SP600125 
SSC    Sus scrofa 
SSC-H    Side scatter heigth 
SUP    Supernatant 
TBE    Tris-borate-EDTA 
TBS    Tris buffered saline 
TBS-T    Tris buffered saline with Tween 
TEMED    N,N,N’,N’-tetramethylethylenediamine 
TGF    Transforming growth factor 
Thr    Threonine 
TIMP    Tissue inhibitor of metalloproteinase 
TNF    Tumor necrosis factor 
Tris    Tris(hydroxymethyl)aminomethane 
Tyr    Tyrosine 
U    Units 
U    Uracil 
U0    U0126 
v    Frequency 
Val    Valine 
VCAM    Vascular cell adhesion molecule 
VE-cadherin  Vascular endothelial cadherin 
VEGF    Vascular endothelial growth factor 
VN    Vitronectin 
vs.    Versus 
vWF    Von Willebrand Factor 
w/v    Weight/volume 
α    Angle 
μ    Micro 
μ    Viscosity 
τ    Shear stress 
ω    Angular velocity 
Ø    Diameter 
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2 ALPHABETICAL LIST OF COMPANIES 
Abcam Cambridge, MA, USA 
AbD Serotec Kidlington, UK 
Alexis Corporation Laeufelfingen, Switzerland 
American Diagnostica Inc. Stamford, CT, USA 
Amersham Biosciences Freiburg, Germany 
Apotheke Innenstadt Munich, Germany 
Applichem GmbH Darmstadt, Germany 
Aurion Wageningen, The Netherlands 
B. Braun Melsungen AG Melsungen, Germany 
Bachem AG Bubendorf, Schweiz 
BD Biosciences Bedford, MA, USA 
BD Pharmingen Heidelberg, Germany 
Beckman Coulter Krefeld, Germany 
Becton Dickinson Heidelberg, Germany 
Biochrom AG Berlin, Germany 
Biomers.net Ulm, Germany 
Biometra Goettingen, Germany 
Bio-Rad Munich, Germany 
Biotec-Fischer Reiskirchen, Germany 
Biozym Scientific GmbH Hess. Oldendorf, Germany 
Calbiochem San Diego, CA, USA 
Carl Zeiss MicroImaging GmbH Goettingen, Germany 
Cell Signaling Danvers, MA, USA 
Chemicon Temecula, CA; USA 
Corning Incorporated Corning, NY, USA 
Dako Glostrup, Denmark 
Eppendorf AG Hamburg, Germany 
Eurofins MWG GmbH Ebersberg, Germany 
Fermentas St. Leon-Rot, Germany 
Fluka Chemie AG Buchs, Switzerland 
GE Healthcare Uppsala, Sweden 
Genaxxon Bioscience GmbH Biberach, Germany 
Gibco Invitrogen Karlsruhe, Germany 
Greiner Bio-One Kremsmünster, Austria 
H&P Labortechnik AG Oberschleissheim, Germany 
Hamamatsu Photonics Herrsching am Ammersee, Germany 
Harbor Bio-Products Norwood, MA, USA 
Heraeus Instruments Osterode, Germany 
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Hettich Zentrifugen Tuttlingen, Germany 
Hoefer Holliston, MA, USA 
Ibidi GmbH Martinsried, Germany 
Invitrogen Eugene, OR, USA 
Ismatec SA, Labortechnik Glattbrugg, Germany 
Leica Microsystems Wetzlar, Germany 
Leitz Wetzlar, Germany 
Lilly Bad Homburg, Germany 
Merck KGaA Darmstadt, Germany 
Miltenyi Biotec Bergisch Gladbach, Germany 
Molecular Probes Inc. Eugene, OR, USA 
New England Biolabs Frankfurt, Germany 
PAA Laboratories GmbH Pasching, Austria 
Peqlab Biotechnologie GmbH Erlangen, Germany 
Perbio Bonn, Germany 
Philips Eindhoven, The Netherlands 
Polysciences Inc. Warrington, PA, USA 
Promocell Heidelberg, Germany 
Qiagen Hilden, Germany 
R&D Systems Minneapolis, MN, USA 
Radiometer Copenhagen Bronshoj, Denmark 
Ratiopharm Ulm, Germany 
Reichert-Jung Vienna, Austria 
Roche Mannheim, Germany 
Rockland Immunochemicals Gilbertsville, PA, USA 
Santa Cruz Heidelberg, Germany 
Sanyo Electric Co. Ltd. Munich, Germany 
Sartorius Stedim Biotech Goettingen, Germany 
Schleicher & Schuell BioScience GmbH  Dassel, Germany 
Serva Electrophoresis GmbH Heidelberg, Germany 
Sigma-Aldrich Chemie GmbH Steinheim, Germany/ 
Taufkirchen, Germany 
Sigma-Aldrich Inc. St. Louis, MO, USA 
SPSS Inc. Chicago, IL, USA 
Tecan Crailsheim, Germany 
Thermo Scientific Rockford, IL, USA 
Upstate Lake Placid, NY, Germany 
Vector Laboratories Burlingame, CA, USA 
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3 PUBLICATIONS 
3.1 ORAL COMMUNICATIONS 
Elastase-dependent signaling cascades in FGF-2 release. 
IV. Symposium, German Research Foundation (DFG), Research Training Group GRK 438 – 
Vascular  Biology in Medicine, November 10–11, 2007, Herrsching am Ammersee, Germany. 
 
Elastase treatment induces αvβ3 integrin-dependent activation of focal adhesion complexes. 
88th Annual meeting, German Physiological Society, March 22–25, 2009, Giessen, Germany. 
3.2 POSTER PRESENTATIONS 
Elastase-dependent signaling cascades in FGF release. 
Hennig, T., Pohl, U., Gloe, T. 
Annual Meeting of the Society for Microcirculation and Vascular Biology 2007 and 6th 
International Symposium on the Biology of Endothelial Cells, October 4–6, 2007, Heidelberg, 
Germany. 
 
Regulation of FGF-2 release via elastase-activated integrin αvβ3. 
Hennig, T., Pohl, U., Gloe, T. 
87th Annual meeting, German Physiological Society, March 2–5, 2008, Cologne, Germany. 
 
Proteolysis of extracellular matrix proteins by elastase induces an activation of focal contacts. 
Hennig, T., Pohl, U., Gloe, T. 
Interact PhD Symposium 2009, April 2, 2009, Munich, Germany. 
 
Outside-in signaling – effects of elastase on extracellular matrix, integrin αvβ3 and 
cytoskeleton. 
Hennig, T., Pohl, U., Gloe, T. 
Joint Meeting 2009 of the Society for Microcirculation and Vascular Biology and the Swiss 
Society for Microcirculation, October 8–10, 2009, Bern, Switzerland. 
 
Shear stress-induced integrin αvβ3 activation is dependent on the activity of an endothelial 
elastase 
Hennig, T., Pohl, U., Gloe, T. 
Joint meeting of FEPS and the Slovenian and Austrian Physiological Societies 2009, 
November 12–15, 2009, Ljubljana, Slovenia. 
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Shear stress induces integrin activation by eliciting release of an endothelial elastase 
Hennig, T., Pohl, U., Gloe, T. 
Joint Meeting of the Scandinavian and German Physiological Societies, March 27–30, 2010, 
Copenhagen, Denmark. 
accepted 
3.3 ORIGINAL PUBLICATIONS 
Shear stress induces the release of an endothelial elastase: role in integrin αvβ3-mediated 
FGF-2 release 
Theres Hennig*, Christina Mogensen*, Ulrich Pohl and Torsten Gloe 
* These authors contributed equally to this work. 
in preparation 
3.4 AWARDS 
Best Poster Award 
Joint meeting of FEPS and the Slovenian and Austrian Physiological Societies 2009, 
November 12–15, 2009, Ljubljana, Slovenia. 
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